Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5389.2;vagina: 1705.5"	"Cell type enriched"	"Detected in some"	24	"Squamous epithelial cells: 79.9"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					NA	NA		100000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								1.0	0.9	0.1	0.0	0.1	0.0	0.7	0.0	0.2	413.5	0.0	0.6	0.0	0.8	0.0	5389.2	0.7	1.1	1.8	0.1	0.1	0.6	1.5	0.4	0.0	0.1	0.1	0.0	1.2	3.0	0.0	3.5	0.0	0.1	0.8	0.0	0.0	914.1	0.0	1.4	7.5	1.2	0.1	0.1	0.9	5.0	0.8	0.1	0.0	0.6	0.0	252.0	1.2	1705.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.9	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63542369-63569329	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 59.5;vagina: 25.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		8200000					"unprognostic (7.35e-2)"				"prognostic favorable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.1	0.0	0.1	0.1	3.3	0.3	0.2	6.6	0.2	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.7	0.0	0.2	59.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	3.5	0.0	0.1	2.1	0.0	25.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TMPRSS11B	HATL5	ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245694	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 393.8;lymphoid tissue: 82.9;vagina: 119.2"	"Group enriched"	"Detected in some"	22	"Early spermatids: 10.4;Late spermatids: 14.5;Squamous epithelial cells: 8.2"	"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA							"unprognostic (4.24e-2)"				"prognostic favorable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.2	27.1	0.1	0.0	0.0	0.0	0.0	393.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.0	59.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.3	0.4	0.2	0.0	0.0	0.0	82.9	0.0	119.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	8.2	0.0	0.0	0.1	0.0	0.0	0.2
AMTN	"RSTI689, UNQ689"	ENSG00000187689	Amelotin	Q6UX39	4	70518569-70532743	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Biomineralization, Cell adhesion"		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 28.5;salivary gland: 6.8;stomach 1: 7.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 14.0;Ionocytes: 4.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 13.9;head and neck cancer: 38.3;lung cancer: 12.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 16.7;hTERT-RPE1: 23.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036136, HPA036137"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA036136: AB_2674963, HPA036137: AB_10673614"	"unprognostic (1.72e-1)"	"unprognostic (2.47e-1)"				"unprognostic (2.04e-1)"		"unprognostic (2.36e-1)"			"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.86e-2)"		"unprognostic (7.35e-2)"	"unprognostic (2.55e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	7.3	0.0	0.1	0.3	0.0	0.0	28.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.7	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	23.7	0.1	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.5	14.0	0.0	0.0	0.1	0.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.2;skin 1: 138.4;vagina: 54.8"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.3	0.3	0.3	0.6	0.4	0.5	18.2	0.8	0.6	12.0	0.6	0.2	0.1	0.3	10.6	70.2	1.0	0.3	0.6	0.5	0.6	0.3	0.4	1.9	1.0	0.3	0.4	0.3	0.1	0.3	0.0	0.5	10.9	0.5	17.6	0.2	0.0	21.0	18.2	42.7	138.4	0.2	0.3	0.2	0.3	0.4	3.4	0.6	23.3	0.3	12.5	17.9	18.8	54.8	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.4	0.8	0.6	0.5	0.6	0.3	0.4	0.3	0.5	0.2	0.6	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TNNI2	"AMCD2B, DA2B, FSSV"	ENSG00000130598	"Troponin I2, fast skeletal type"	P48788	11	1838981-1841680	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	25	"skeletal muscle: 8045.8;tongue: 2645.6"	"Group enriched"	"Detected in many"	6	"Extravillous trophoblasts: 449.4;Skeletal myocytes: 598.7"	"Group enriched"	"Detected in many"	10	"cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 86.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 35.7;hTCEpi: 101.2"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 5.1"	"Not detected"	"Not detected"			"CAB018697, HPA055938"	Enhanced		Approved	"Plasma membrane,Intermediate filaments"		NA	NA		110000	"Plasma membrane"	"Intermediate filaments"	"CAB018697: AB_628400, HPA055938: AB_2682976"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-2)"	2.3	1.8	0.3	1.1	0.3	6.1	8.0	0.3	0.6	0.9	0.4	1.2	0.3	0.8	0.3	67.4	0.9	5.6	1.5	0.3	0.3	0.7	1.6	7.9	1.6	0.4	0.3	0.3	0.7	8.8	0.0	0.9	3.0	0.4	14.1	0.2	0.0	217.9	3.2	8045.8	55.6	2.7	0.2	0.4	5.8	1.1	0.7	0.4	1.9	2.8	2645.6	1.0	27.7	3.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	35.7	1.0	0.2	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	8.1	101.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	3.1	0.0	0.1	1.2	2.4	0.0	1.0	0.0	1.0	0.0	0.7	0.0	0.0	12.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	13.8	5.8	53.3	0.1	12.5	0.1	3.8	0.0	0.0	8.0	4.8	0.0	0.0	39.7	0.4	17.6	86.4	0.0	2.5	0.3	0.3	0.3	0.6	0.3	0.3	0.4	0.3	0.3	0.4	0.4	0.4	0.5	1.2	3.2	4.4	0.0	9.1	25.1	2.6	1.8	15.4	0.0	0.5	23.7	5.6	21.5	3.0	0.0	0.0	33.8	15.7	0.1	0.0	1.4	0.0	1.4	0.2	2.0	0.0	0.0	0.0	0.6	449.4	2.4	1.1	0.1	10.8	0.4	0.4	0.3	39.6	0.0	0.0	0.0	2.0	18.8	10.7	0.0	0.3	25.9	0.0	0.0	16.0	0.0	1.0	0.0	0.0	1.4	0.0	0.0	4.2	0.1	0.0	0.2	13.2	0.0	0.0	598.7	2.4	0.0	0.6	2.7	6.5	87.2	1.9	4.3	0.0	0.9
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"esophagus: 84.4"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 40.7"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"SiHa: 112.2"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	1.3	0.3	0.0	0.1	0.0	0.4	0.6	0.9	0.6	0.3	0.1	0.2	0.0	0.0	84.4	0.0	0.0	0.0	0.3	0.1	0.6	4.3	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	5.7	0.0	0.0	3.4	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	5.3	0.4	7.1	0.9	0.0	1.8	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	112.2	7.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.9	0.3	0.1	0.4	0.3	0.3	0.5	0.2	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.4	2.3	1.3	4.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.7	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	40.7	1.7	0.0	0.0	0.0	0.5	8.5
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 701.9;vagina: 246.5"	"Group enriched"	"Detected in some"	5	"Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052028	Enhanced					NA	NA					"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	64.9	0.0	0.1	0.0	0.1	0.0	701.9	0.2	0.0	0.1	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	107.7	0.0	0.3	0.2	0.1	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.1	0.0	13.6	0.2	246.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.3	0.1	0.0	32.0
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 86.9;lymphoid tissue: 28.7;vagina: 42.0"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA					"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	9.5	0.0	0.0	0.0	0.0	0.0	86.9	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.4	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.1	0.0	0.0	28.7	0.3	42.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.2	0.2	0.5	0.8	0.7	0.0	1.0	0.1	0.7	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105653-69118719	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.8;urinary bladder: 93.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 162.3;Basal prostatic cells: 51.6;Basal respiratory cells: 107.1;Suprabasal keratinocytes: 158.6;Urothelial cells: 115.5"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 52.5;PC-3: 270.5;RT4: 111.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.8	0.5	0.8	0.8	1.0	0.9	7.5	1.1	1.1	2.8	0.7	5.4	2.9	0.9	1.2	33.8	1.2	4.9	0.7	0.5	0.9	1.1	1.3	20.2	0.4	0.9	0.9	0.7	1.4	1.3	0.4	1.7	3.4	1.2	3.7	3.1	0.8	5.4	1.5	1.2	7.8	2.3	0.6	0.3	0.8	12.9	3.6	0.9	0.6	6.0	1.0	2.9	93.7	10.4	1.0	3.5	17.1	1.0	0.9	0.3	0.4	6.6	1.1	0.4	1.0	0.4	3.4	9.0	0.7	2.0	0.4	4.0	52.5	2.9	31.5	1.0	0.2	1.3	0.0	0.2	0.6	0.1	0.3	0.9	0.5	8.6	1.0	3.0	4.0	0.7	0.6	0.1	0.4	0.3	1.8	1.2	0.7	15.5	18.7	270.5	2.0	0.1	0.2	28.3	111.6	19.2	0.8	1.8	0.1	0.3	3.1	0.6	0.8	0.3	0.9	0.9	29.9	1.8	1.0	0.9	0.2	1.0	0.0	0.6	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.8	1.0	1.1	1.1	0.5	0.9	0.9	0.9	0.7	1.2	0.3	0.9	1.0	4.2	0.0	30.8	0.7	0.2	162.3	51.6	107.1	8.6	1.1	1.6	6.1	1.4	0.0	12.2	0.0	2.1	1.0	0.1	16.4	0.0	4.5	10.2	0.7	0.3	2.4	0.0	0.4	1.0	3.6	0.9	1.1	5.1	2.7	0.0	0.4	1.1	0.2	0.3	0.0	2.1	0.7	2.0	0.0	6.5	22.7	1.2	0.5	3.6	0.0	0.0	0.1	0.0	0.5	0.8	2.4	0.2	0.4	0.6	18.4	0.1	0.7	3.0	1.0	0.0	0.9	1.9	0.5	0.7	25.6	158.6	0.3	1.1	0.1	2.2	115.5
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 84.7;Basal respiratory cells: 52.0;Basal squamous epithelial cells: 120.1;Ionocytes: 87.5;Langerhans cells: 124.0;Suprabasal keratinocytes: 106.1"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	11	"cerebral cortex: 5.3;pons: 1.3"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 176.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 176.7"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 118.4"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	22.4	0.3	0.1	9.9	0.1	22.3	7.6	0.1	5.3	4.9	0.3	0.6	0.9	0.2	0.3	41.2	0.7	0.8	0.7	0.2	0.2	3.8	2.9	12.0	0.6	0.1	0.1	0.1	0.1	0.2	5.5	0.3	4.6	1.3	3.5	0.3	0.2	14.3	14.8	0.2	27.8	1.0	0.3	0.1	26.2	1.5	2.8	0.2	10.6	0.5	1.9	10.2	7.0	14.2	0.2	4.5	0.4	0.1	0.1	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	118.4	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.1	3.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.5	0.2	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	38.7	2.5	2.6	0.0	5.3	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	176.7	0.0	23.9	0.0	0.0	1.4	0.1	0.1	0.1	5.3	0.2	0.2	0.1	0.1	0.1	1.3	0.1	0.2	0.2	0.4	0.0	4.3	0.0	0.5	94.4	84.7	52.0	120.1	0.5	3.4	1.1	0.1	0.0	40.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	24.9	0.4	0.2	1.2	0.0	0.0	0.0	0.0	26.3	2.4	0.0	0.3	2.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	87.5	4.1	124.0	2.7	0.0	17.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	8.5	0.1	0.0	0.1	1.4	0.0	0.1	47.2	106.1	2.6	1.5	0.0	0.0	32.5
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEK 293: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Uncertain	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3821.0;breast: 2214.1"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3821.0	42.6	0.8	47.1	0.9	2.8	2214.1	0.9	1.6	10.0	29.3	53.4	2.8	4.7	0.6	15.3	11.0	68.8	93.4	1.2	0.9	7.0	5.2	114.5	13.7	0.9	0.8	0.7	4.2	16.7	59.6	1.5	188.5	0.9	4.3	33.8	2.6	59.2	5.1	67.2	57.7	45.1	14.3	0.8	6.7	26.7	1.1	3.1	30.1	83.7	168.2	2.0	245.2	19.1	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.9	1.6	1.2	0.9	0.9	0.8	0.7	0.9	0.8	3.1	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364059-89388160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 329.9"	"Cell type enriched"	"Detected in some"	25	"Squamous epithelial cells: 325.0"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"A-431: 5.4;HaCaT: 11.3"					"Low region specificity"	"Detected in all"			HPA027744	Enhanced					NA	NA					"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	12.4	0.1	0.0	0.0	0.1	0.1	329.9	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.4	0.2	0.2	0.4	0.1	0.0	0.8	0.0	0.5	0.1	0.0	0.1	63.3	0.1	0.2	0.9	0.0	0.0	0.3	0.2	0.3	0.0	0.4	1.1	0.2	0.2	55.5	0.1	32.3	0.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	11.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.3	0.3	0.7	0.2	0.1	0.1	0.6	0.1	0.2	0.2	0.3	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.2	12.5	0.1	0.0	0.0	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.5	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.4	0.0	0.0	12.8	0.0	0.0	0.0	1.2	0.0	0.1	325.0	0.0	0.0	0.2	1.2	0.0	1.2
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229742-46231243	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 113.9;salivary gland: 34.8;vagina: 31.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.7;Basal respiratory cells: 12.5;Prostatic glandular cells: 4.4;Squamous epithelial cells: 2.1;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 6.9;RT4: 25.6;SK-BR-3: 8.6"									HPA014001	Uncertain				"Secreted in other tissues"	NA	NA					"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	113.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	34.8	0.0	0.0	3.0	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.8	0.0	0.0	4.9	0.4	31.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	6.9	0.0	1.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	12.5	0.0	0.0	0.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.3	2.1	3.4	0.0	0.0	0.0	0.0	0.2
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 1034.1;skin 1: 301.4;vagina: 493.4"	"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 906.1;Basal prostatic cells: 596.6;Suprabasal keratinocytes: 1348.4;Urothelial cells: 506.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.9;cerebral cortex: 2.0;hippocampal formation: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTCEpi: 816.8"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		1700000000	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	6.7	1.4	0.1	0.1	0.3	0.3	17.5	3.9	2.0	147.3	2.0	0.2	0.0	1.0	0.0	1034.1	0.7	2.4	0.4	1.0	0.0	0.7	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.7	0.0	1.4	0.1	0.1	6.4	0.0	0.0	182.0	38.1	0.5	301.4	0.2	0.1	0.0	0.2	0.6	2.6	0.0	17.0	0.3	0.0	113.0	5.6	493.4	0.4	20.0	1.7	0.0	0.0	0.2	0.0	0.2	1.5	0.4	0.5	0.2	0.3	4.9	0.1	2.9	0.1	0.2	24.8	0.0	5.6	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	816.8	0.3	17.6	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.0	0.3	0.0	127.1	0.7	0.0	0.2	98.1	0.8	6.2	0.0	0.0	57.1	1.5	0.0	0.9	0.0	0.0	0.2	0.0	1.6	4.5	0.4	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	3.9	2.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	906.1	596.6	70.1	16.5	0.0	37.8	27.1	0.1	0.0	94.6	1.8	0.0	0.1	0.6	0.0	0.0	1.0	0.0	2.6	0.6	9.2	0.0	0.0	0.0	5.8	3.2	11.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	94.1	0.0	0.3	1.1	64.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	127.3	0.0	0.0	17.1	0.0	0.0	0.0	9.3	0.0	0.3	88.1	1348.4	0.1	3.4	0.0	0.0	506.9
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 396.2;skin 1: 779.8"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 275.1;Squamous epithelial cells: 639.7;Suprabasal keratinocytes: 725.7"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 7.1;OE19: 2.2"	"Low region specificity"	"Detected in single"							"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"	NA	NA		4000000			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	0.7	0.2	0.0	0.0	0.0	0.0	13.8	0.0	0.0	30.5	0.0	0.2	0.0	0.4	0.0	396.2	0.4	0.2	0.5	0.0	0.0	0.7	0.3	0.4	0.0	0.1	0.1	0.0	0.3	0.4	0.0	0.4	0.0	0.0	2.0	0.0	0.0	25.7	0.2	10.8	779.8	0.3	0.0	0.0	2.3	0.5	1.5	0.0	0.5	0.7	0.4	2.3	0.3	156.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	275.1	0.9	124.3	89.4	0.0	0.3	2.8	0.2	0.0	57.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	7.5	1.1	0.0	0.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.4	10.7	0.0	0.0	1.7	3.8	1.5	0.8	639.7	725.7	0.0	0.5	0.1	0.0	1.5
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784882-142786539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2091.0;skin 1: 855.3;vagina: 495.3"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 1171.6;Squamous epithelial cells: 1913.0;Suprabasal keratinocytes: 3866.1"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"A-431: 162.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					NA	NA		210000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	1.1	48.0	0.4	0.2	0.5	0.0	20.7	0.4	1.4	143.5	0.4	0.9	0.0	0.3	0.0	2091.0	1.0	1.4	0.7	0.6	0.4	0.3	0.8	0.5	0.0	0.4	0.4	0.4	0.5	1.0	0.0	1.0	2.6	0.5	15.4	0.2	0.0	237.3	0.3	2.6	855.3	0.5	0.0	0.4	0.5	12.5	0.4	0.4	4.7	0.4	0.0	76.2	65.7	495.3	0.6	162.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	6.0	0.0	1.3	0.0	0.2	0.0	0.0	4.0	11.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	1.2	4.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	1.4	0.6	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.6	0.1	3.2	0.0	0.0	0.0	1171.6	9.4	244.9	138.3	0.0	14.8	14.1	0.2	0.0	154.0	1.8	0.0	0.9	0.1	0.4	1.9	1.1	0.0	0.4	0.1	10.7	0.0	0.0	0.3	0.2	5.7	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	22.4	0.0	137.3	0.0	0.0	0.8	163.7	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	2.5	18.9	0.0	1.2	12.2	0.0	0.0	0.6	16.1	0.0	0.0	1913.0	3866.1	8.2	4.0	0.0	0.4	164.6
TMPRSS11F	"FLJ16046, HATL4"	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129869	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"esophagus: 15.3;lymphoid tissue: 4.1;skin 1: 9.3;vagina: 4.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 6.9"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"K-562: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026911	Uncertain					NA	NA					"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.1	1.0	0.0	0.1	9.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	4.1	0.0	4.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.5	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	6.9	0.0	0.3	0.0	0.1	0.0	0.5
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 324.5;liver: 485.9;skeletal muscle: 289.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	324.5	21.0	12.3	10.1	11.0	1.0	207.4	10.9	10.8	11.4	8.8	26.1	29.9	5.7	3.3	204.1	8.7	99.0	54.4	7.2	11.9	16.3	485.9	23.7	2.1	18.2	13.4	7.3	10.4	11.9	1.1	8.2	0.8	17.6	11.8	13.4	15.3	117.4	13.1	289.2	39.3	34.0	9.3	12.6	2.1	138.2	12.0	18.8	4.5	38.6	36.8	9.3	256.4	47.4	18.8	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.3	11.0	10.9	10.8	7.2	11.9	18.2	13.4	7.3	17.6	12.6	18.8	18.8	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499570	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 2852.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 172.1;Breast myoepithelial cells: 156.1;Suprabasal keratinocytes: 390.7"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"A-431: 400.3"					"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favorable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	2.5	0.5	0.0	0.0	0.0	0.1	41.6	0.0	0.0	45.1	0.0	0.7	0.0	0.3	0.7	68.0	0.1	0.0	1.2	0.0	0.0	0.3	1.8	0.8	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.0	0.6	0.0	0.0	558.9	0.0	11.8	2852.4	0.6	0.0	0.0	0.4	0.8	1.0	0.0	9.3	0.6	0.0	13.5	0.1	309.1	0.0	400.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.8	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	27.3	0.3	2.2	0.0	0.0	172.1	156.1	0.2	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	11.1	0.0	0.0	0.4	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.2	0.3	6.8	390.7	0.0	1.2	0.0	0.0	3.3
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958423-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Club cells: 18.7;Oligodendrocytes: 14.9;Respiratory ciliated cells: 39.6;Syncytiotrophoblasts: 14.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 36.4"	"Low region specificity"	"Detected in some"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.4	1.2	0.3	1.6	1.0	0.8	1.3	1.9	2.1	0.5	0.6	0.4	0.6	0.5	3.4	2.0	0.4	0.7	1.1	0.9	0.4	0.3	2.1	0.4	1.6	1.6	1.0	0.3	0.5	0.3	1.7	0.4	1.9	8.0	0.3	0.4	2.0	0.5	1.0	0.5	0.8	0.4	0.8	0.8	1.2	0.7	1.5	0.9	0.6	0.3	3.0	2.7	1.3	2.9	0.0	0.7	0.2	0.0	0.6	0.2	0.4	0.2	0.0	0.1	0.0	0.8	0.8	0.1	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.1	7.9	0.1	0.1	0.0	0.3	0.3	0.1	1.1	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.0	0.1	0.0	0.0	0.7	0.1	36.4	0.8	0.1	0.4	0.2	0.1	0.4	0.2	0.4	0.2	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.3	1.9	1.1	0.9	1.6	1.6	1.0	1.9	0.8	1.5	2.9	4.3	6.4	6.1	17.9	0.1	0.1	1.2	6.6	0.0	0.5	1.6	0.5	0.7	0.0	18.7	0.0	0.0	1.7	0.0	0.2	0.0	0.0	3.2	2.1	0.4	2.1	0.0	2.5	9.3	0.0	0.0	0.3	0.0	0.4	1.3	0.0	0.7	0.1	0.6	0.0	8.4	0.0	6.1	1.3	0.4	1.7	0.0	1.4	0.0	7.5	0.6	0.2	1.0	7.1	14.9	0.0	0.0	0.0	0.4	10.9	0.2	0.1	39.6	0.0	0.0	0.5	2.4	0.9	0.2	0.2	0.0	14.9	0.2	0.1	0.2	7.4
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 612.9;pancreas: 179.9"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	0.8	0.0	2.2	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	612.9	0.0	0.0	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.8	0.5	1.2	0.1	179.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.3	2.3	2.9	0.4	0.8	0.5	1.2	0.6	0.3	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 104.8;esophagus: 51.3;skin 1: 56.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Group enriched"	"Detected in many"	6	"cerebellum: 104.8;pons: 32.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5"	"Region enriched"	"Detected in some"	18	"cerebellum: 32.0"	"Region enriched"	"Detected in many"	56	"cerebellum: 224.4"	CAB033680	Enhanced					NA	NA		300000			"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.3	0.2	0.2	0.0	3.6	0.1	3.7	104.8	3.6	6.2	0.0	0.1	0.1	0.1	1.7	51.3	1.0	0.0	0.1	0.5	1.0	0.2	0.1	0.2	0.0	11.7	6.4	0.1	0.1	0.2	0.2	0.5	0.9	32.7	5.3	0.0	0.1	9.0	4.8	0.2	56.4	0.2	0.0	0.3	0.1	0.1	13.3	1.2	2.2	0.1	0.0	3.5	2.9	24.6	6.6	1.7	0.0	0.0	0.1	0.0	0.0	35.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	21.0	0.0	0.2	51.7	0.0	23.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	70.5	0.0	3.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.1	0.0	0.1	1.1	0.2	0.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	104.8	3.6	0.5	1.0	11.7	6.4	0.1	32.7	0.3	1.2	6.6	0.1	0.0	0.0	0.7	0.0	18.0	5.8	31.6	27.9	0.0	3.4	12.8	1.9	0.0	11.1	1.8	0.0	0.4	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.3	0.0	0.0	5.0	0.0	20.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.0	1.5	7.8	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.1	3.0	0.0	0.0	0.0	0.4	0.5	0.1	53.2	19.6	1.0	0.1	0.0	0.0	13.0
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316820	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.2;skin 1: 33.0;vagina: 24.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.1	0.0	0.2	0.0	3.3	0.1	0.9	5.1	2.4	0.0	0.0	0.0	3.3	36.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	9.6	0.1	4.4	0.0	0.0	13.8	5.6	0.1	33.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.5	0.0	0.0	12.5	13.3	24.0	0.5	110.8	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.2	0.0	40.8	0.0	0.0	0.0	0.6	90.6	0.0	116.7	1.1	0.0	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	152.8	0.1	62.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	6.1	0.0	0.0	0.0	3.8	46.7	0.0	0.0	19.0	0.5	0.0	3.1	0.4	0.1	0.0	0.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.9	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.0	1.1	1.0	0.0	59.3	139.2	150.0	46.7	0.0	2.8	1.8	0.1	0.0	49.9	3.7	0.0	59.0	0.4	0.0	0.0	1.2	0.7	3.3	0.0	1.5	0.0	0.0	1.1	0.7	8.7	1.1	0.0	2.4	1.3	0.0	0.0	0.0	4.2	0.0	0.4	0.0	28.5	0.0	3.6	0.1	0.0	0.6	10.6	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	60.6	0.0	0.1	19.6	0.0	0.0	0.0	4.1	0.0	0.0	52.7	68.2	205.0	0.9	0.0	0.0	211.4
IFNK		ENSG00000147896	"Interferon kappa"	Q9P0W0	9	27524290-27526498	"Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"brain: 3.9;choroid plexus: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA							"unprognostic (5.58e-3)"				"unprognostic (4.64e-3)"								"unprognostic (1.06e-1)"				0.0	0.0	0.9	0.0	3.3	0.0	0.0	1.3	1.4	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	2.9	2.1	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.3	1.3	1.4	0.5	1.6	2.9	2.1	0.2	2.3	2.1	2.5	3.9	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MT4	MTIV	ENSG00000102891	"Metallothionein 4"	P47944	16	56565073-56568957	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 116.0"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 19.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 6.7;endometrial cancer: 11.6"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA																				"unprognostic (8.81e-2)"			0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	1.9	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	116.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	6.3	0.0	0.0	0.0	0.0	18.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.8	19.7	0.0	0.0	0.0	0.0	0.0
PAX7	Hup1	ENSG00000009709	"Paired box 7"	P23759	1	18630846-18748866	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 5.1;skeletal muscle: 5.8;tongue: 4.4"	"Cell type enriched"	"Detected in some"	284	"Skeletal myocytes: 341.4"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.5;cervical cancer: 1.5;lung cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.4;CAPAN-2: 1.4;U-2 OS: 3.0"	"Region enriched"	"Detected in single"	17	"midbrain: 4.6"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"							NA	NA						"unprognostic (8.41e-4)"	"unprognostic (2.07e-1)"			"unprognostic (5.35e-2)"	"unprognostic (3.96e-2)"		"unprognostic (4.21e-1)"						"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"			0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.2	5.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.0	0.0	4.4	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	1.4	0.2	0.1	3.2	5.1	0.3	1.5	2.0	0.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	341.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PRR9		ENSG00000203783	"Proline rich 9"	Q5T870	1	153217584-153219310	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 37.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 4.1;Late spermatids: 10.2;Syncytiotrophoblasts: 8.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.2;endometrial cancer: 4.1;head and neck cancer: 11.8;melanoma: 3.4;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SuSa: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027714	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA027714: AB_10602194"		"unprognostic (1.45e-1)"	"unprognostic (1.46e-1)"			"unprognostic (4.17e-1)"			"unprognostic (3.48e-1)"	"unprognostic (7.02e-2)"					"unprognostic (8.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-2)"	0.7	0.0	0.1	0.0	0.1	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.1	0.0	0.0	2.9	0.1	0.7	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923133-56934408	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 14.7;skin 1: 56.8;vagina: 21.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 1.2;Suprabasal keratinocytes: 4.0"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.0	0.1	0.0	2.7	0.2	0.3	5.6	0.0	0.2	0.0	0.4	0.0	14.7	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	4.1	0.0	0.8	56.8	0.1	0.0	0.0	0.2	0.1	0.9	0.0	0.5	0.0	0.0	7.5	0.2	21.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.0	0.0	0.0	0.0	0.0	0.0
SMC1B	"bK268H5, SMC1L2"	ENSG00000077935	"Structural maintenance of chromosomes 1B"	Q8NDV3	22	45344063-45413619	"Predicted intracellular proteins"	"Cell cycle, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	98	"testis: 31.3"	"Group enriched"	"Detected in some"	6	"Spermatocytes: 897.6;Spermatogonia: 448.5"	"Cancer enriched"	"Detected in many"	6	"cervical cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001500	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001500: AB_1080030"	"unprognostic (1.18e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.83e-9)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.98e-3)"	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.2	0.1	0.0	18.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.4	0.0	3.9	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	75.6	0.5	0.2	0.8	0.0	0.0	1.4	0.0	0.9	0.3	0.0	0.2	0.0	0.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	36.9	5.6	0.5	0.0	1.0	0.0	0.3	0.0	1.0	1.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.2	1.0	98.6	0.4	0.2	897.6	448.5	0.0	0.0	0.8	0.1	0.0	0.0	0.2
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.9;salivary gland: 6.9;vagina: 10.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Hofbauer cells: 2.8;Oligodendrocyte precursor cells: 1.0;Prostatic glandular cells: 5.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enhanced"	"Detected in some"		"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	74	"HeLa: 3708.0;SiHa: 2339.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	0.6	0.2	0.0	0.0	0.5	0.0	0.2	2.7	0.8	2.7	0.0	1.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.3	6.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.1	0.0	0.6	10.2	1.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.5	3708.0	4.0	0.0	0.6	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2339.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.3	40.8	0.2	0.1	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.7	0.8	0.2	0.2	0.5	0.6	0.1	0.8	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.8	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.4	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor Kazal type 7"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 625.4;vagina: 619.0"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 49.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted in other tissues"	NA	NA		230000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.2	122.6	0.1	0.0	0.0	0.1	0.1	625.4	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.5	0.0	0.7	0.0	0.2	0.1	0.0	0.0	141.2	0.0	0.2	7.4	0.1	0.1	0.1	0.1	4.2	0.1	0.1	4.8	0.1	0.1	117.0	0.6	619.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	4.5
SYCP2	SCP2	ENSG00000196074	"Synaptonemal complex protein 2"	Q9BX26	20	59863564-59933655	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 43.5"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 468.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 6.7;cervical cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.9;JURKAT: 47.2;MOLT-4: 54.4;SiHa: 92.2;T-47d: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062401, HPA065613"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA062401: AB_2684752, HPA065613: AB_2685519"	"unprognostic (8.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-1)"	"unprognostic (7.02e-3)"	"unprognostic (4.84e-3)"	"unprognostic (8.48e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	3.3	0.8	2.5	1.5	3.2	2.4	14.1	10.2	4.7	2.1	0.2	1.3	1.7	1.6	1.2	1.0	1.3	2.4	2.0	2.6	2.0	4.4	1.1	2.2	2.6	3.3	3.1	1.8	0.7	6.7	0.7	1.9	4.0	5.3	3.8	1.1	1.5	4.4	1.0	1.3	2.8	2.4	0.7	1.6	3.1	6.2	43.5	2.2	1.3	2.4	1.0	1.7	1.8	1.5	4.2	0.3	1.3	0.2	1.4	0.6	0.8	1.4	4.1	1.1	1.8	0.2	25.9	2.6	0.1	4.0	1.8	0.8	0.6	0.5	0.1	1.0	8.5	0.6	0.2	6.1	0.4	0.2	0.4	19.0	0.4	0.4	0.4	0.0	0.9	0.0	47.2	0.2	0.0	0.9	12.5	54.4	2.9	0.4	1.5	0.3	0.0	0.1	0.2	2.1	6.1	0.2	4.5	92.2	13.3	3.3	1.6	82.6	4.7	0.5	0.1	2.8	11.2	0.0	0.0	0.0	0.0	0.0	1.7	5.2	0.7	0.1	0.7	0.8	0.0	0.8	0.2	0.4	0.5	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.0	0.3	0.2	2.5	3.2	10.2	4.7	2.6	2.0	3.3	3.1	1.8	5.3	1.6	2.2	4.2	11.5	0.0	1.1	24.5	1.4	1.0	1.1	1.0	0.0	1.9	12.7	9.4	3.6	2.8	6.3	1.8	2.1	0.8	3.0	0.1	1.9	0.9	82.3	0.4	5.0	6.5	0.0	0.0	27.5	3.6	0.4	2.1	2.6	0.5	2.5	1.2	2.9	0.0	0.5	0.0	14.6	0.1	0.0	1.2	0.8	21.8	4.7	1.6	5.4	13.1	1.4	2.3	5.2	28.6	11.1	1.2	1.2	1.9	0.4	1.8	0.3	5.4	8.6	1.1	52.6	1.7	3.8	468.5	92.4	0.6	0.0	0.4	4.1	0.2	0.3	1.2
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447463-68497604	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 221.9;vagina: 157.6"	"Cell type enriched"	"Detected in some"	14	"Ionocytes: 476.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;OE19: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043816, HPA051062"	Enhanced		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA			"Golgi apparatus"		"HPA043816: , HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavorable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	42.8	0.0	0.0	0.0	0.0	18.4	221.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.2	0.0	0.0	57.1	0.7	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	24.7	6.5	157.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	12.9	0.7	0.0	0.0	0.5	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.3	6.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	476.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.2	6.6	0.3	1.1	0.7	0.0	0.0	32.6
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.3;lymphoid tissue: 2.6;skin 1: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 33.3;U-87 MG: 45.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.0	0.0	2.5	0.0	3.3	0.0	0.2	6.3	3.0	0.5	0.9	0.0	0.0	0.0	0.4	0.8	0.0	0.2	0.0	2.0	2.4	0.0	0.0	0.0	0.0	4.0	3.8	1.8	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	2.2	0.0	0.1	0.0	3.1	0.0	0.0	0.0	2.6	0.1	0.6	4.7	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.4	5.2	0.0	0.0	0.0	33.3	0.3	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.5	0.3	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.1	1.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.3	6.3	3.0	2.0	2.4	4.0	3.8	1.8	5.1	2.2	3.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441156-33447596	"Blood group antigen proteins, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1538.3;urinary bladder: 695.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1923.3;Basal prostatic cells: 982.0;Collecting duct cells: 1609.3;Prostatic glandular cells: 1430.8;Squamous epithelial cells: 2189.3;Suprabasal keratinocytes: 2485.4;Urothelial cells: 2455.4"	"Group enriched"	"Detected in all"	5	"cervical cancer: 319.0;head and neck cancer: 283.7;lung cancer: 146.8;urothelial cancer: 221.3"	"Region enhanced"	"Detected in many"		"pons: 21.3"	"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 181.7;T-reg: 205.4"	"Lineage enriched"	"Detected in many"	18	"T-cells: 205.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 127.1;HeLa: 213.2;JURKAT: 130.7;RT4: 216.6;SK-BR-3: 149.7;U-266/70: 151.2;U-266/84: 213.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	8.4	2.1	1.6	16.9	1.0	19.9	37.0	1.9	3.4	90.8	1.3	10.4	74.0	11.0	3.0	1538.3	25.6	9.5	23.2	4.6	1.4	113.2	119.6	115.0	16.2	13.7	7.1	1.1	12.2	43.5	2.0	2.8	6.1	21.3	86.4	10.2	1.7	403.2	37.1	5.3	514.5	101.3	3.3	0.3	111.0	36.1	2.8	1.0	236.0	2.3	26.9	174.0	695.4	534.2	6.7	0.6	38.6	1.9	0.0	67.7	12.2	1.0	0.3	0.9	0.9	1.1	20.5	12.0	0.5	9.1	0.0	0.5	127.1	6.2	0.7	0.2	61.6	6.0	4.3	213.2	1.9	0.4	1.3	1.3	1.9	6.5	0.5	0.2	0.2	0.5	130.7	67.4	58.8	6.9	29.1	60.4	23.0	5.3	88.6	0.7	0.9	94.3	10.8	1.3	216.6	1.7	4.7	32.3	149.7	0.1	8.0	0.9	10.6	1.2	0.0	1.0	0.4	0.4	151.2	213.6	14.5	0.5	0.4	0.2	1.6	0.5	0.1	20.2	0.4	181.7	11.3	171.9	52.8	0.3	3.0	97.3	47.1	2.3	3.0	0.5	11.1	205.4	43.0	1.6	1.0	1.9	3.4	4.6	1.4	13.7	7.1	1.1	21.3	0.3	1.0	6.7	9.2	38.5	249.9	0.0	42.4	1923.3	982.0	381.4	811.0	9.7	56.8	27.8	3.4	157.3	436.3	1609.3	2.1	0.9	21.6	2.7	0.0	37.4	2.2	82.3	21.4	37.1	8.3	71.4	0.3	48.9	2.0	27.5	16.3	96.2	20.8	0.2	16.4	137.3	2.2	0.0	0.1	104.0	315.3	3.5	122.9	0.6	33.2	15.3	158.3	0.0	1.6	0.4	4.1	0.5	0.2	28.5	8.1	1.2	246.9	1430.8	343.1	31.9	546.0	0.5	0.0	10.2	35.8	0.7	1.9	2189.3	2485.4	50.2	73.4	1.6	7.3	2455.4
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924697-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	862	"intestine: 4860.0"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 448.9;Undifferentiated cells: 904.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 21.2;colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 14.7;NB-4: 15.9;RPMI-8226: 19.7;SH-SY5Y: 12.2;U-2197: 5.7"									HPA019462	Enhanced				"Secreted to digestive system"	NA	NA		260000			"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.2	0.0	5.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	16.3	2888.7	2.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.2	3.4	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.3	3.4	0.0	0.3	0.0	0.2	0.5	4860.0	0.0	0.0	0.2	0.4	0.6	0.0	2.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	12.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.0	0.0	0.0	0.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	448.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	904.1	0.0
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935577-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 425.2;vagina: 173.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1044.3;Basal respiratory cells: 596.2;Squamous epithelial cells: 528.5;Suprabasal keratinocytes: 786.2;Urothelial cells: 303.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 117.5;head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 556.3;HBEC3-KT: 968.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.5	0.1	0.0	1.8	0.0	0.1	13.6	0.0	0.0	57.1	0.0	17.6	1.8	0.5	0.1	425.2	1.2	0.3	0.1	0.0	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	1.1	0.0	1.8	15.7	0.0	60.1	0.1	0.1	77.6	7.0	1.1	0.0	0.1	2.0	0.0	0.0	0.3	0.7	0.0	38.7	15.1	173.7	0.0	150.7	10.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	189.0	0.0	10.9	0.0	0.2	556.3	0.0	968.2	0.0	0.0	1.2	0.0	2.0	0.0	0.2	0.0	0.4	0.1	141.0	0.0	17.7	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	7.9	75.2	0.0	0.0	0.0	93.4	6.7	0.0	0.0	0.2	0.0	0.2	0.0	0.9	0.5	0.1	0.2	0.3	0.0	0.3	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	8.4	0.0	0.3	1044.3	182.5	596.2	217.4	0.0	11.8	3.2	0.1	0.0	223.2	0.0	0.0	0.2	0.2	49.6	0.0	49.7	0.0	52.8	3.3	6.3	0.0	0.0	0.0	7.5	2.4	6.2	0.0	65.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.1	42.7	0.0	60.6	0.0	0.0	0.9	74.7	0.0	0.6	0.0	1.0	0.0	0.0	139.1	50.8	0.0	0.0	90.8	0.7	0.0	56.8	0.0	0.0	0.0	10.4	0.0	0.0	528.5	786.2	2.3	2.1	0.0	26.1	303.6
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.9;parathyroid gland: 13.2;testis: 8.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 7.0;Excitatory neurons: 5.9;Inhibitory neurons: 24.2;Spermatocytes: 13.1"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 11.3;hTCEpi: 10.1;hTERT-HME1: 33.4;LHCN-M2: 13.5;U-251 MG: 9.6;U-87 MG: 10.2;WM-115: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	0.4	0.2	2.4	0.9	1.4	0.3	0.3	0.1	2.6	0.4	0.8	0.6	0.6	0.2	0.1	0.7	0.2	0.9	0.1	2.9	6.3	0.1	0.4	0.2	0.6	1.5	3.1	1.3	0.1	0.2	13.2	0.1	0.3	2.0	0.2	0.9	0.1	0.3	0.1	0.9	0.4	1.4	0.3	0.8	1.1	0.7	8.8	7.9	0.2	0.1	0.5	0.4	2.3	0.6	1.5	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.7	0.3	0.7	1.0	0.0	1.2	0.0	0.0	0.1	2.0	4.7	1.3	11.3	2.8	0.0	0.2	0.0	0.0	0.0	5.1	0.0	0.6	7.8	10.1	3.3	33.4	6.3	0.0	0.0	0.1	0.0	13.5	0.0	0.0	0.2	1.2	0.0	1.6	1.0	0.1	0.0	0.0	1.2	0.4	0.0	0.5	0.0	5.4	0.6	0.0	0.2	0.3	6.1	0.0	0.1	9.6	0.0	0.0	0.0	10.2	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.4	0.1	2.6	2.9	6.3	1.5	3.1	1.3	2.0	0.8	7.9	1.5	0.1	0.0	0.0	0.7	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.4	0.0	1.7	0.0	24.2	0.0	2.0	2.2	0.0	2.7	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	13.1	1.3	0.0	0.1	0.1	0.2	0.0	0.0	0.3
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"esophagus: 111.6;skin 1: 164.6;vagina: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6"	"Not detected"	"Not detected"							HPA063914			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.7	0.2	0.1	0.0	0.2	0.0	10.4	0.2	0.6	11.8	0.5	0.5	0.0	0.2	0.0	111.6	0.4	0.0	0.5	0.2	0.1	0.2	5.4	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.3	0.4	0.2	2.2	0.5	0.0	13.8	0.2	1.0	164.6	0.4	0.0	0.2	0.3	0.5	3.8	0.3	2.0	0.5	0.9	9.6	1.3	66.7	0.2	27.2	0.0	0.1	0.4	15.4	64.9	2.6	0.6	1.8	0.3	1.2	2.7	3.4	0.2	14.9	9.7	1.0	86.0	0.0	140.0	0.7	0.4	0.0	0.3	19.5	0.0	91.8	0.2	0.2	11.5	555.6	4.5	102.6	0.7	0.1	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.4	2.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	54.6	0.0	2.8	4.7	0.5	0.9	0.0	0.2	1.8	0.5	0.5	0.1	0.2	0.2	8.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.6	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.7	0.0	0.0	0.7	0.0	36.8	1.7	115.8	60.9	0.0	0.3	0.5	0.4	0.0	43.0	0.0	0.0	1.7	0.8	0.8	0.0	0.9	57.0	0.7	0.4	0.9	0.0	0.0	1.0	0.2	1.4	3.9	0.0	0.8	0.0	0.2	0.0	2.2	0.4	0.0	1.2	0.7	10.2	0.3	6.6	28.8	0.3	0.6	3.6	1.0	1.7	0.0	1.0	1.0	0.2	1.0	0.1	0.7	0.4	1.3	0.2	0.3	5.5	0.0	0.0	0.6	3.6	1.7	1.9	56.5	38.1	1.6	0.6	0.2	0.5	5.3
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 16.0;prostate: 10.0;salivary gland: 9.5;skin 1: 20.2;vagina: 12.3"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 48.6;Basal squamous epithelial cells: 50.7;Breast myoepithelial cells: 15.6;Prostatic glandular cells: 13.3;Squamous epithelial cells: 26.5;Suprabasal keratinocytes: 20.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 5.4;head and neck cancer: 7.3;lung cancer: 1.8;prostate cancer: 6.9;testis cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.8;HaCaT: 16.3;HBEC3-KT: 8.1;MCF7: 8.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 1.2;pons: 1.5"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.1	0.0	0.4	0.0	0.0	0.1	3.2	0.7	0.2	1.7	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.9	10.0	0.0	0.0	9.5	0.0	0.6	20.2	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	12.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	16.3	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	8.3	1.1	0.1	0.1	4.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.2	0.0	0.0	0.7	0.6	0.0	0.9	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	48.6	2.8	0.1	50.7	0.0	1.4	15.6	6.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.1	26.5	20.2	3.7	0.0	0.0	0.0	1.7
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383448-51394730	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 23.1;seminal vesicle: 19.4;vagina: 16.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 207.5;Cytotrophoblasts: 34.4;Enteroendocrine cells: 91.6;Horizontal cells: 43.7;Syncytiotrophoblasts: 34.2"	"Group enriched"	"Detected in some"	5	"cervical cancer: 1.1;pancreatic cancer: 4.1;prostate cancer: 2.1;stomach cancer: 1.6;testis cancer: 1.4"	"Group enriched"	"Detected in many"	4	"hypothalamus: 7.8;thalamus: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 297.1"	"Group enriched"	"Detected in many"	8	"basal ganglia: 13.8;hypothalamus: 15.0;thalamus: 6.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 5.8;hypothalamus: 5.4"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	1.3	1.4	0.8	0.0	1.3	0.0	0.1	0.0	1.4	4.7	0.0	1.1	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.0	4.8	0.0	2.2	7.9	1.2	12.1	2.4	23.1	1.2	19.4	0.0	1.1	0.7	0.1	0.1	0.0	10.1	1.6	3.6	4.3	0.3	0.0	0.4	0.7	16.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.0	3.8	0.0	0.0	0.3	2.7	0.0	2.5	0.0	0.0	2.2	4.6	3.4	0.0	0.0	7.1	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	3.2	0.0	3.0	0.0	0.0	0.0	19.1	297.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.4	0.0	7.8	0.7	0.3	0.5	1.2	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	1.5	5.1	11.8	0.0	207.5	0.0	0.0	0.2	0.0	2.8	0.0	4.2	34.4	0.0	0.5	0.0	0.1	17.3	0.0	0.0	1.7	91.6	0.0	0.0	0.0	10.9	6.1	11.7	0.0	0.0	0.0	0.0	0.0	2.7	43.7	0.0	1.9	8.2	0.0	0.4	3.2	0.3	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.1	0.0	0.0	0.8	11.8	0.0	0.0	4.0	2.5	7.3	0.0	1.0	34.2	0.0	0.0	0.2	5.6
IVL		ENSG00000163207	Involucrin	P07476	1	152908546-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 77.5;esophagus: 300.7;salivary gland: 95.3;skin 1: 145.7;vagina: 237.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 10.4;Squamous epithelial cells: 30.8;Suprabasal keratinocytes: 71.0;Urothelial cells: 13.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"HaCaT: 292.9;RT4: 76.9;SK-BR-3: 86.3"					"Not detected"	"Not detected"			"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		NA	NA		4700000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	77.5	0.0	0.0	0.0	0.0	18.4	300.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.0	95.3	0.1	0.4	145.7	0.1	0.0	0.0	0.1	0.2	0.1	0.0	3.6	0.1	0.0	37.2	17.6	237.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	292.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	0.0	0.0	0.0	86.3	0.0	0.2	3.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.1	3.5	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.6	0.0	0.0	30.8	71.0	0.0	0.1	0.0	0.0	13.3
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45091214-45101127	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 23.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Cholangiocytes: 7.2;Collecting duct cells: 1.8;Excitatory neurons: 6.2"	"Cancer enriched"	"Detected in many"	5	"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 23.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.3;HHSteC: 2.1;hTEC/SVTERT24-B: 1.0;THP-1: 1.8;U-87 MG: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.0	0.4	2.7	0.1	5.0	0.1	0.2	0.0	23.9	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	5.2	1.8	0.1	0.0	0.2	0.0	1.1	1.2	3.1	0.0	0.0	0.0	0.2	0.0	3.8	0.3	0.0	0.1	1.5	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.1	0.3	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.8	0.0	0.9	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	5.0	0.0	23.9	5.2	1.8	1.1	1.2	3.1	3.8	0.0	0.1	10.0	0.0	0.0	2.0	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.1	1.1	7.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41253.5;vagina: 13518.8"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	6.8	7.5	0.0	0.0	0.1	6.9	5.2	0.0	0.0	3290.9	0.0	4.9	0.1	10.3	0.0	41253.5	7.1	8.9	9.3	0.0	0.1	5.5	12.9	6.0	0.3	0.0	0.0	0.0	9.9	17.3	0.0	27.1	0.0	0.0	116.2	0.0	0.0	6935.6	3.9	9.9	13.5	8.6	14.3	0.0	7.8	31.5	7.0	0.0	13.7	6.1	0.0	1871.4	933.9	13518.8	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 3.1;salivary gland: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.7;head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 9.4;HMC-1: 5.6"					"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"							NA	NA		280000000				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814116	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"esophagus: 19918.5"	"Cell type enriched"	"Detected in some"	18	"Squamous epithelial cells: 5828.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"HaCaT: 734.9;SK-BR-3: 361.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		NA	NA		600000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (6.26e-4)"	1.3	1.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	246.0	0.0	1.0	0.0	1.2	0.0	19918.5	9.6	3.2	7.2	0.0	0.0	0.9	2.6	17.5	0.0	0.0	0.0	0.0	1.8	2.8	0.0	8.9	0.0	0.0	4.4	0.0	0.0	2140.9	0.0	2.6	3.2	1.7	0.9	0.0	1.6	8.7	0.8	0.0	2.0	1.0	0.1	1430.5	4.4	1048.7	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.8	0.0	0.1	0.0	734.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.5	1.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.4	0.0	0.2	0.0	15.5	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.0	361.6	0.0	0.0	2.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	1.0	0.9	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	3.3	0.0	0.0	0.0	6.5	36.9	23.3	0.0	0.5	2.9	0.5	0.0	308.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.5	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.9	6.9	0.0	0.1	53.7	0.0	0.0	0.0	5.3	0.0	0.1	5828.7	0.0	0.0	2.0	0.0	0.0	54.4
KRT79	"K6L, KRT6L"	ENSG00000185640	"Keratin 79"	Q5XKE5	12	52821408-52834311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 43.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Late spermatids: 1.1;Melanocytes: 3.6"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;cervical cancer: 2.6;head and neck cancer: 2.7;melanoma: 1.6;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HMC-1: 425.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059347	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA		1900000000	"Nucleoplasm, Nuclear membrane, Cytosol"		"HPA059347: AB_2683986"	"unprognostic (5.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-2)"		"unprognostic (6.85e-2)"		"unprognostic (6.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.88e-2)"			"unprognostic (1.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.99e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	425.5	0.0	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 100.5;choroid plexus: 45.0;retina: 34.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 68.6;Early spermatids: 43.1;Muller glia cells: 254.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;GAMG: 17.9;HAP1: 23.5;HeLa: 15.5;NTERA-2: 28.5;U-138 MG: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000838		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.1	0.1	71.4	0.2	73.4	0.0	0.2	43.4	100.5	0.0	45.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	86.2	70.0	0.0	6.7	0.0	0.3	50.1	48.7	70.6	0.2	0.0	0.0	9.9	3.4	57.0	0.0	0.1	34.4	0.1	0.0	0.0	4.5	0.2	0.0	42.9	0.1	0.0	3.1	46.3	0.1	0.0	0.0	0.2	0.1	0.0	71.8	0.0	7.2	0.2	23.2	0.0	0.3	2.6	0.7	0.3	1.8	0.2	7.8	0.0	0.2	3.0	1.4	17.9	0.2	23.5	0.0	0.9	0.0	5.0	0.0	15.5	0.4	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	12.1	0.0	0.2	28.5	0.0	7.0	6.5	0.1	0.0	0.0	0.1	9.2	0.1	5.7	0.0	0.0	0.2	8.0	3.1	0.0	14.6	0.6	4.2	1.1	0.4	5.0	0.0	0.8	3.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.4	73.4	43.4	100.5	86.2	70.0	50.1	48.7	70.6	57.0	42.9	46.3	71.8	0.1	0.0	0.0	68.6	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	43.1	0.1	0.0	0.3	0.0	0.0	20.6	0.0	8.9	0.1	0.0	0.0	0.0	0.1	3.9	0.0	4.0	8.4	2.5	0.0	0.0	0.0	0.3	21.7	0.0	0.1	0.0	1.9	0.0	254.6	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.4	0.2	4.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 159.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 20.1;Breast myoepithelial cells: 15.1;Cardiomyocytes: 13.4;Endometrial ciliated cells: 24.0;Erythroid cells: 16.6;Hepatic stellate cells: 27.5;Skeletal myocytes: 48.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 7.7;cervical cancer: 27.0;urothelial cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 5.3;K-562: 12.8;NB-4: 24.1;NTERA-2: 4.5;SCLC-21H: 6.4;SH-SY5Y: 5.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"CAB017029, HPA043412, HPA051005"	Enhanced					NA	NA					"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	4.5	159.8	15.1	0.2	23.1	2.1	8.5	17.5	13.8	5.9	6.1	4.0	0.5	4.4	1.4	3.0	9.1	0.3	18.3	8.7	14.9	2.4	0.5	9.0	0.3	25.7	20.2	9.6	3.0	1.8	7.5	30.9	3.3	20.0	8.6	0.0	0.1	3.2	21.5	21.3	3.0	7.3	0.2	9.2	2.2	7.0	4.5	19.8	0.1	1.8	17.7	0.0	6.6	5.9	10.6	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.9	5.3	0.2	0.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	24.1	4.5	0.5	0.1	0.1	0.0	0.3	0.0	0.0	6.4	5.8	0.1	2.3	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.1	23.1	17.5	13.8	8.7	14.9	25.7	20.2	9.6	20.0	9.2	19.8	10.6	3.1	0.0	0.0	1.0	0.5	0.5	0.7	0.0	0.0	0.3	20.1	15.1	13.4	1.5	0.0	5.5	0.0	0.1	1.1	0.1	1.9	0.0	0.7	24.0	2.6	5.0	3.0	16.6	0.5	0.0	0.9	1.1	0.0	9.0	0.0	0.7	27.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.5	2.1	0.2	0.0	1.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.0	0.5	0.0	48.0	0.8	1.0	2.3	0.0	0.4	0.0	11.0	0.0	0.3	1.8
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 93.9;NK-cells: 164.8;Oligodendrocytes: 26.6;T-cells: 33.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 11.7;head and neck cancer: 8.0;lung cancer: 3.7;urothelial cancer: 6.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 299.4;MAIT T-cell: 184.9;memory CD8 T-cell: 144.9;naive CD8 T-cell: 109.3"	"Lineage enriched"	"Detected in many"	7	"T-cells: 299.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.5;HBEC3-KT: 10.9;RT4: 18.7;T-47d: 11.6;U-2 OS: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced					NA	NA					"HPA029683: AB_10603237"	"unprognostic (9.07e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.55e-4)"	"unprognostic (4.21e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.46e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-1)"	0.6	0.4	29.7	0.8	41.5	19.9	0.6	39.0	38.2	2.8	17.3	0.3	0.2	0.3	4.4	12.9	0.2	0.2	0.5	26.8	34.0	0.7	1.6	3.0	1.0	45.3	42.3	22.4	0.2	1.5	0.1	0.4	1.7	43.9	2.5	0.1	0.0	2.5	0.5	0.6	18.9	0.3	0.2	36.5	11.2	0.3	0.7	38.1	0.9	0.5	0.2	2.1	2.3	11.0	67.6	1.9	2.8	0.6	0.0	0.0	0.1	0.2	0.6	0.5	0.9	0.5	0.3	0.1	0.0	7.6	0.3	1.2	28.5	1.8	10.9	2.0	0.0	1.8	0.2	2.3	0.0	0.1	0.0	0.1	0.0	5.0	3.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	3.7	1.1	0.0	4.5	0.6	0.5	0.0	2.1	0.0	0.0	18.7	0.0	0.0	4.7	0.0	0.5	1.9	11.6	3.3	0.0	1.5	10.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.5	0.5	1.2	299.4	0.2	184.9	0.6	36.3	144.9	0.6	0.5	10.8	109.3	3.9	44.5	1.1	0.8	0.6	64.2	29.7	41.5	39.0	38.2	26.8	34.0	45.3	42.3	22.4	43.9	36.5	38.1	67.6	1.0	3.2	1.9	0.0	0.6	3.6	2.2	10.9	7.4	0.0	0.1	0.9	0.9	1.5	0.9	0.0	0.0	0.1	93.9	0.0	0.0	0.0	6.2	0.1	0.2	0.6	0.0	0.8	0.1	0.2	0.3	1.7	0.5	0.0	2.5	0.0	1.8	0.3	0.2	0.0	0.1	0.0	0.0	0.8	0.3	2.3	0.0	0.6	0.0	2.8	1.2	0.0	164.8	0.0	26.6	0.2	0.0	0.0	14.7	0.2	0.0	0.1	0.4	0.0	0.0	0.1	1.9	0.0	0.2	4.8	5.1	0.1	33.1	0.0	0.0	0.4
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 181.9;vagina: 136.1"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 58.8;Club cells: 54.8;Squamous epithelial cells: 148.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 45.9;head and neck cancer: 27.6;lung cancer: 12.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	129	"HaCaT: 198.9;hTCEpi: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA		210000	"Nuclear speckles, Cytosol"		"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	27.2	0.0	0.0	0.0	0.0	0.0	181.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	36.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	23.1	3.3	136.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.7	1.9	58.8	13.1	0.0	0.0	0.1	0.1	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	8.5	0.0	0.0	0.0	1.0	0.0	0.0	148.6	1.3	0.5	0.0	0.0	0.0	19.9
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644256	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;vagina: 152.1"	"Cell type enriched"	"Detected in some"	4	"Basal respiratory cells: 3577.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.1;head and neck cancer: 29.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;HSkMC: 1.1;SiHa: 1.7;U-2197: 6.1"									"HPA048341, HPA049988, HPA055992"	Supported					NA	NA		10000000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	37.8	0.0	0.0	0.0	0.6	0.0	94.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.3	0.0	0.0	23.5	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.5	21.2	152.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	3577.0	0.0	0.0	0.0	0.0	0.0	0.0	825.8	0.0	0.0	0.0	0.0	0.0	0.0	23.9	1.4	0.1	0.1	0.2	0.0	0.0	0.0	21.7	0.2	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	97.6	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	32.4	0.0	0.3	53.0	0.0	0.0	0.0	10.7	0.1	0.0	14.8	0.0	0.8	0.0	0.0	0.0	60.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849384	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1;skin 1: 13.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 59.5;Late spermatids: 191.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016662	Enhanced					NA	NA					"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	5.2	0.3	0.1	0.7	0.2	0.0	2.8	0.1	0.3	1.7	0.1	0.4	0.1	0.5	0.3	9.1	0.6	1.0	0.6	0.1	0.9	0.1	0.1	0.3	0.1	0.2	0.3	0.0	0.1	0.8	0.6	0.2	0.1	0.2	0.4	0.3	0.0	1.5	0.2	0.7	13.2	0.2	1.0	0.1	0.2	0.3	4.3	0.7	0.3	1.0	1.1	1.2	1.0	4.7	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.9	0.2	0.3	0.0	0.2	0.1	0.7	0.7	9.3	0.0	0.0	6.2	0.0	13.8	0.0	0.8	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	1.7	1.0	2.6	0.0	0.0	2.5	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.2	191.7	1.5	0.1	0.0	2.8	0.0	0.0	0.0	3.5	4.8	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.2	1.2	0.6	6.0	24.9	0.0	0.0	0.0	0.0	0.2
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135704498	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 29.1;choroid plexus: 12.1;testis: 17.0"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 78.3"	"Group enriched"	"Detected in some"	5	"cervical cancer: 2.3;endometrial cancer: 0.6;head and neck cancer: 2.3;lung cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 20.9;U-266/84: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.1	0.0	13.4	0.0	15.7	0.0	0.0	12.8	29.1	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	12.7	0.0	0.0	0.0	0.0	16.4	13.4	14.5	0.1	0.0	0.1	3.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	12.3	0.1	0.1	17.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.7	12.8	29.1	15.1	12.7	16.4	13.4	14.5	16.8	12.3	12.8	18.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	15.9	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	78.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SPRR2F		ENSG00000244094	"Small proline rich protein 2F"	Q96RM1	1	153112121-153113516	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 266.8;lymphoid tissue: 70.8;ovary: 113.4"	"Cell type enriched"	"Detected in some"	29	"Granulosa cells: 681.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 16.0;head and neck cancer: 53.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"K-562: 2.7"															NA	NA							"unprognostic (7.40e-2)"		"unprognostic (1.14e-2)"		"unprognostic (1.48e-2)"		"unprognostic (2.41e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.57e-1)"				"unprognostic (2.54e-1)"	"unprognostic (2.96e-1)"		"unprognostic (1.78e-3)"	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.1	0.0	266.8	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	113.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.4	6.7	0.0	0.1	0.0	0.1	70.8	0.1	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	18.8	0.0	0.0	0.0	681.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	23.0	0.0	0.7	0.0	0.0	0.0	0.2	4.5	0.0	0.3
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.5;skin 1: 63.8;urinary bladder: 40.9"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 184.7;Basal squamous epithelial cells: 520.2;Breast myoepithelial cells: 192.9;Cholangiocytes: 183.0;Extravillous trophoblasts: 201.8;Respiratory ciliated cells: 163.8;Squamous epithelial cells: 132.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 10.5;pancreatic cancer: 21.7;urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 32.2;hTCEpi: 50.2;T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047239, HPA052700"	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA047239: , HPA052700: AB_2681920"	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.2	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.1	0.0	0.2	0.5	0.0	0.5	29.5	1.0	8.7	0.0	0.0	0.0	0.3	0.6	4.7	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.2	1.6	0.0	2.5	0.0	0.0	21.0	3.0	0.0	63.8	2.6	0.0	0.0	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.1	40.9	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	32.2	0.0	0.0	0.0	0.6	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.2	0.0	5.8	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.1	1.0	0.0	0.3	0.0	2.7	0.0	0.0	13.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.0	3.9	0.0	0.3	184.7	5.6	24.9	520.2	0.0	3.2	192.9	0.6	183.0	39.1	5.5	0.0	28.7	0.7	3.4	0.0	31.1	0.0	15.6	0.1	1.7	0.0	0.0	0.0	9.7	201.8	1.6	12.2	0.6	1.3	0.0	0.0	0.1	7.1	0.0	0.0	1.3	16.2	0.0	14.7	0.0	0.0	1.3	10.6	0.0	0.0	0.0	0.0	0.0	0.0	28.3	3.5	0.0	6.2	1.3	18.3	0.0	163.8	0.0	0.0	0.0	7.0	0.0	0.0	132.5	47.2	36.8	0.6	0.1	1.7	31.5
TMPRSS11D	"ASP, HAT"	ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884002	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"cervix: 24.6;esophagus: 72.4;lymphoid tissue: 34.7;salivary gland: 21.2;vagina: 76.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 24.4;Club cells: 13.8;Inhibitory neurons: 3.9;Oligodendrocyte precursor cells: 5.0;Urothelial cells: 12.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077704	Enhanced				"Intracellular and membrane"	NA	NA					"HPA077704: "	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.3	2.7	24.6	0.7	0.0	0.0	0.0	0.0	72.4	0.0	0.0	0.0	1.5	1.5	0.0	0.0	0.0	0.0	2.7	1.6	0.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	1.1	0.2	0.0	0.0	34.7	0.6	76.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	2.7	1.5	1.5	2.7	1.6	0.9	2.8	0.6	1.1	2.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	24.4	0.6	0.0	0.0	0.0	0.3	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.0	1.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	12.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.2;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA					"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.2	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.3	12.2	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skin 1: 50.8"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.1;Pancreatic endocrine cells: 6.3;Prostatic glandular cells: 1.8;Spermatocytes: 1.8;Spermatogonia: 1.7;Suprabasal keratinocytes: 1.8"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 3.9;melanoma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.4;HBEC3-KT: 10.1;hTCEpi: 7.3;hTERT-HME1: 13.7;T-47d: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.0	0.0	1.0	0.0	0.3	0.0	1.7	1.5	2.3	0.3	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.9	0.7	0.4	0.0	0.1	0.4	0.2	0.1	1.3	0.1	0.0	0.1	0.3	0.0	0.1	50.8	0.0	0.0	0.2	0.0	0.0	0.8	1.4	0.0	0.0	0.0	1.2	0.0	1.9	1.6	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.1	0.5	0.2	0.2	0.1	2.9	0.4	0.8	10.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.1	13.7	0.0	0.0	0.9	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.4	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	1.5	2.3	1.2	0.3	0.9	0.7	0.4	1.3	0.2	1.4	1.6	0.1	0.0	0.0	0.0	0.0	0.3	2.1	1.2	0.0	0.0	0.6	0.5	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.1	0.1	0.2	0.0	0.0	1.2	0.9	1.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	1.7	0.3	1.8	1.1	0.0	0.0	0.0	0.6
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 219.4;skin 1: 268.4;vagina: 111.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Astrocytes: 38.8;Club cells: 40.7;Excitatory neurons: 47.8;Fibroblasts: 34.5;Inhibitory neurons: 41.0;Microglial cells: 35.6;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 48.1;Squamous epithelial cells: 63.6"	"Group enriched"	"Detected in many"	4	"cervical cancer: 14.3;head and neck cancer: 16.1;lung cancer: 4.3;urothelial cancer: 11.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 394.3;HBEC3-KT: 622.3;hTCEpi: 357.6;hTERT-HME1: 134.2;RT4: 159.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	33.4	0.7	0.4	0.1	0.3	0.7	11.8	0.8	1.0	24.8	0.4	0.4	0.0	0.1	1.0	219.4	3.8	0.4	2.5	0.5	0.1	0.0	1.8	13.2	0.0	0.8	0.5	0.2	1.3	0.3	0.0	0.3	31.2	0.6	12.5	0.1	0.0	47.7	9.9	0.4	268.4	0.2	0.0	0.5	0.2	0.4	0.8	0.9	4.8	0.2	0.2	47.0	67.0	111.6	0.8	123.4	16.2	0.0	0.0	0.0	0.0	33.7	2.3	0.3	0.0	0.0	8.7	35.0	0.0	2.5	1.0	1.8	394.3	0.0	622.3	0.0	27.9	0.0	0.0	39.6	0.0	26.2	0.0	1.3	0.2	357.6	0.2	134.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.2	0.1	4.0	0.0	0.0	0.5	0.0	0.0	159.6	0.0	0.0	56.4	16.4	0.3	8.7	0.1	3.5	0.0	0.0	39.5	0.7	2.4	0.2	0.1	0.2	4.4	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.3	0.8	1.0	0.5	0.1	0.8	0.5	0.2	0.6	0.5	0.9	0.8	0.1	99.3	7.3	38.8	0.0	1.1	10.3	1.6	2.8	0.0	4.9	3.4	2.6	7.2	40.7	3.7	0.0	14.7	0.1	1.0	0.0	3.1	0.6	2.1	0.0	0.5	0.0	0.0	47.8	0.4	6.7	34.5	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.0	41.0	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	35.6	0.1	0.0	0.0	50.8	48.1	17.3	0.0	0.0	0.0	8.5	1.5	0.0	14.2	0.0	0.0	0.0	0.6	0.2	1.4	63.6	2.0	6.2	0.3	0.1	0.2	17.2
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 94.8;lymphoid tissue: 48.7;urinary bladder: 24.6"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	21.1	0.5	94.8	0.8	0.6	1.0	1.2	1.0	1.5	1.4	0.4	0.3	12.3	4.3	6.4	1.3	0.8	0.4	0.7	2.0	13.5	1.1	0.6	0.5	0.4	0.2	1.6	0.4	0.3	3.6	0.5	0.4	0.6	0.2	6.8	0.3	0.5	0.6	0.9	1.7	0.3	48.7	1.1	0.2	0.4	2.4	1.0	3.7	21.3	24.6	10.4	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.6	1.0	0.8	0.4	0.6	0.5	0.4	0.5	0.3	0.4	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 183.1;esophagus: 196.8;intestine: 222.5;lung: 289.2;salivary gland: 179.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"OE19: 1799.0"									"CAB008370, HPA011041"	Enhanced					NA	NA		86000000			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	2.1	0.4	0.3	30.0	1.0	183.1	2.7	0.5	0.6	19.2	0.0	196.9	33.3	0.6	1.8	196.8	8.3	131.3	0.2	0.2	0.0	0.3	0.7	289.2	0.3	0.3	0.1	0.1	0.4	5.3	0.1	0.3	0.5	0.2	2.4	222.5	0.0	179.1	1.4	0.1	6.2	24.6	6.7	0.0	2.4	15.7	0.4	0.2	2.2	0.3	0.0	32.7	9.7	79.7	0.5	0.1	162.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.5	4.6	0.0	0.2	0.0	0.5	19.4	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.1	11.2	0.1	0.2	0.2	1799.0	4.5	0.1	0.0	0.1	1.0	0.7	1.8	0.1	0.0	4.2	0.0	0.2	0.6	1.9	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.1	0.0	3.1	0.3	1.0	0.5	0.6	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.5	0.0	942.3	84.5	0.0	2.3	0.0	4.9	17.9	0.0	0.0	3.5	2.0	0.2	75.8	322.1	0.0	0.0	0.0	0.0	640.1	0.0	77.0	0.2	0.4	0.1	1.3	5.4	0.0	0.1	16.3	0.0	1.3	1.5	0.8	7.0	0.0	0.4	0.3	0.0	0.0	0.1	102.3	14.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.7	391.1	0.0	0.0	24.2	5.7	0.0	71.8	0.0	0.0	0.0	9.9	0.0	0.1	15.6	0.0	0.0	1.2	0.0	31.7	182.3
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"esophagus: 3720.6;vagina: 2621.6"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	334.5	15.6	125.4	139.0	120.9	112.7	243.8	122.3	147.7	653.8	284.7	259.2	84.1	63.3	4.8	3720.6	22.6	88.5	248.7	124.3	151.1	16.5	27.8	274.9	193.0	179.1	125.6	109.3	12.2	73.8	447.2	33.0	341.7	163.4	23.1	212.6	33.6	519.0	17.2	120.3	612.9	123.3	52.9	143.2	128.4	182.9	45.5	126.6	138.9	75.5	308.8	295.3	366.0	2621.6	151.6	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	125.4	120.9	122.3	147.7	124.3	151.1	179.1	125.6	109.3	163.4	143.2	126.6	151.6	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416285-47418052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cataract, Disease variant, Peters anomaly"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Cardiomyocytes: 6.0;Spermatogonia: 2.3"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SuSa: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 153.9;esophagus: 173.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 169.0;Breast myoepithelial cells: 113.2;Club cells: 83.1;Endometrial ciliated cells: 146.0;Glandular and luminal cells: 464.0;Urothelial cells: 146.6"	"Group enriched"	"Detected in many"	4	"breast cancer: 35.4;cervical cancer: 49.3;endometrial cancer: 16.8;pancreatic cancer: 41.9;stomach cancer: 25.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"A-431: 215.1;EFO-21: 236.8;HeLa: 166.8;PC-3: 331.3;SuSa: 418.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain					NA	NA					"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	4.5	3.6	13.5	7.3	13.5	10.0	153.9	21.1	19.6	8.7	5.4	4.3	15.5	49.1	19.2	173.1	13.0	27.5	5.4	12.5	12.4	6.1	7.2	14.8	5.7	13.2	9.6	5.5	3.9	24.0	2.0	2.0	9.1	15.5	12.8	5.0	42.5	36.0	16.8	13.8	19.1	16.3	2.7	3.3	7.4	27.6	8.3	14.1	4.7	6.2	2.7	42.6	5.4	29.7	22.3	215.1	9.9	10.1	7.0	0.7	4.3	23.8	3.8	1.5	0.5	0.6	38.1	23.6	3.3	236.8	1.1	2.3	75.7	6.4	0.5	0.6	3.5	7.6	14.1	166.8	5.7	0.8	5.1	11.2	1.6	3.0	2.8	1.8	8.0	1.4	13.4	57.6	26.5	0.4	6.7	9.5	4.7	84.5	3.7	331.3	13.7	6.6	8.2	13.8	11.6	8.2	4.0	76.5	3.9	2.2	418.8	4.2	2.4	8.8	19.1	69.3	15.7	15.7	10.0	6.7	6.3	2.6	13.9	2.9	11.8	1.9	6.1	0.4	1.5	1.1	0.3	0.4	0.3	0.6	0.7	0.5	0.5	4.5	0.2	5.7	0.9	0.6	2.3	13.5	13.5	21.1	19.6	12.5	12.4	13.2	9.6	5.5	15.5	3.3	14.1	22.3	1.1	3.2	0.6	0.0	0.9	0.0	14.9	44.4	0.0	0.0	169.0	113.2	0.7	51.5	83.1	1.8	0.0	5.2	2.3	0.0	0.0	10.4	0.0	146.0	48.8	3.8	0.0	0.0	0.3	13.8	0.6	2.4	2.0	464.0	0.0	0.0	0.0	0.1	2.3	0.0	0.2	0.3	12.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.6	0.1	0.0	0.0	24.2	0.1	0.1	34.0	0.0	0.0	0.2	5.9	0.0	0.0	4.5	0.0	5.7	2.7	0.0	0.6	146.6
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136033-3163749	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.2;esophagus: 109.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8"	"Group enriched"	"Detected in all"	4	"cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 67.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043113	Approved					NA	NA					"HPA043113: AB_10967343"	"prognostic favorable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	5.7	3.2	3.6	12.5	3.7	76.2	4.7	3.8	6.6	7.3	5.5	2.4	1.7	1.3	0.4	109.7	2.4	4.7	1.9	4.6	5.7	2.0	1.4	13.2	4.2	5.2	4.0	3.2	0.8	1.2	0.4	1.4	7.7	4.5	11.7	1.8	0.1	19.6	2.5	0.6	47.7	2.5	3.1	4.8	8.8	4.4	1.4	5.7	32.3	1.2	0.9	12.2	28.3	42.0	5.3	44.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	18.7	0.1	0.1	0.0	0.1	36.2	0.0	65.4	0.0	0.1	0.0	19.1	0.1	0.0	0.0	27.2	152.1	0.0	40.0	0.2	26.2	0.0	0.0	16.6	0.1	0.3	0.0	0.0	162.4	59.8	0.1	2.9	0.0	119.3	0.0	0.2	0.0	23.6	0.2	0.0	4.6	0.2	0.2	0.0	0.0	62.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.3	29.8	0.1	19.4	29.1	14.3	0.0	21.8	1.1	0.0	2.0	0.3	28.8	0.0	0.0	0.0	6.9	4.4	15.5	67.1	8.7	13.3	3.6	3.7	3.8	6.6	4.6	5.7	5.2	4.0	3.2	4.5	4.8	5.7	5.3	1.0	9.6	8.8	0.0	2.2	67.2	141.5	65.5	9.1	0.2	7.4	3.7	0.5	0.0	39.0	3.7	0.0	0.5	27.6	0.5	0.0	0.7	0.5	1.4	0.5	3.1	6.6	21.0	1.3	0.0	0.8	2.5	3.6	3.9	34.3	0.0	0.7	0.0	66.5	0.0	0.4	2.2	57.0	36.2	190.6	0.8	0.0	78.3	21.4	7.5	32.0	0.0	0.0	0.0	0.2	13.2	0.3	0.0	3.6	69.3	0.0	0.1	21.7	0.1	19.7	0.3	3.3	4.0	2.0	38.0	95.8	0.4	19.6	0.1	1.4	173.8
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319357-24364482	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 121.8;skin 1: 52.0;vagina: 48.1"	"Group enriched"	"Detected in some"	5	"Squamous epithelial cells: 113.5;Suprabasal keratinocytes: 99.3;Urothelial cells: 78.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 13.3;head and neck cancer: 16.1;urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 46.1;HaCaT: 36.6;MCF7: 58.5;OE19: 21.2;RT4: 64.8;SuSa: 33.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.2	0.1	0.5	0.3	0.5	0.1	1.9	1.4	2.1	11.1	0.1	0.1	0.6	0.1	1.6	121.8	0.6	0.7	0.0	0.4	1.2	0.2	0.3	0.1	0.0	5.2	2.1	0.0	0.0	0.2	0.9	0.2	1.4	5.0	1.5	0.3	0.1	16.8	1.6	0.1	52.0	0.3	0.0	2.2	0.0	0.5	2.4	1.1	1.0	0.0	0.0	25.3	35.0	48.1	1.8	1.2	2.7	1.0	0.0	0.0	0.0	46.1	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.0	36.6	0.1	3.3	0.0	1.2	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	14.2	0.2	2.7	0.0	0.0	0.0	0.2	0.1	0.0	58.5	0.0	0.2	2.4	21.2	0.0	0.0	0.0	0.2	4.6	64.8	0.3	0.0	0.2	6.3	0.0	33.3	4.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.4	2.1	0.4	1.2	5.2	2.1	0.0	5.0	2.2	1.1	1.8	0.0	0.0	0.6	0.0	0.0	14.4	13.2	5.2	8.6	0.0	1.1	0.3	0.5	0.0	6.4	1.8	0.0	4.1	0.0	0.9	0.0	0.4	0.5	3.8	0.1	0.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.1	2.0	0.3	2.1	0.3	0.0	0.3	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.1	0.2	0.0	3.3	0.0	0.0	0.0	0.3	2.6	0.0	113.5	99.3	18.5	0.0	0.0	0.1	78.4
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 134386.5"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 672352.3"	"Group enriched"	"Detected in all"	4	"cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 658.1;plasmacytoid DC: 379.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 379.7;granulocytes: 658.1"	"Cell line enhanced"	"Detected in some"		"HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2"									"CAB009526, HPA043234"	Enhanced					NA	NA		10000000000			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	1042.1	486.0	418.9	219.2	731.0	134386.5	644.6	502.4	2433.0	349.2	2881.9	255.8	29.1	79.5	46.0	510.2	836.8	799.5	2206.8	384.6	499.0	2306.6	1922.8	4075.1	27.0	534.9	824.6	366.6	291.5	159.9	50.9	814.5	6397.9	921.5	314.8	150.2	31.3	552.9	293.3	584.6	126.3	171.3	66.9	587.8	9299.9	271.4	172.0	936.9	198.6	1161.7	13016.8	40.6	323.4	638.9	1021.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.1	4.2	0.0	0.0	0.0	0.0	99.5	25.3	73.7	37.8	1.3	4.0	21.5	6.8	1.1	35.2	13.8	13.7	39.9	658.1	47.9	5.0	379.7	1.4	22388.9	418.9	731.0	502.4	2433.0	384.6	499.0	534.9	824.6	366.6	921.5	587.8	936.9	1021.6	441.7	3.2	8.4	0.0	280.5	157.0	2.3	5.1	0.0	4.0	54.7	72.0	3.4	217.3	4.5	7.3	4.2	2.2	369.9	5.2	50.9	0.0	0.0	6.8	6.6	151.7	3.6	672352.3	0.0	0.0	11.3	276.1	0.0	5.1	0.0	4.6	443.4	420.5	7.3	3.3	0.0	7.2	6.1	1452.1	702.6	0.0	0.0	1091.0	27383.1	0.0	72.7	9.7	38.1	0.0	0.0	0.1	3.5	0.0	1.9	0.0	0.1	272.4	84.9	117.8	0.0	126.0	396.8	0.0	0.0	0.0	252.5	2.2	769.8	0.3	3.0	0.1
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;esophagus: 16.9;lymphoid tissue: 19.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 94.4;Basal prostatic cells: 81.1;Basal respiratory cells: 57.3;Basal squamous epithelial cells: 159.4;Langerhans cells: 57.4;Squamous epithelial cells: 66.9;Suprabasal keratinocytes: 106.3;Urothelial cells: 66.1"	"Group enriched"	"Detected in some"	4	"cervical cancer: 2.1;head and neck cancer: 2.5;lung cancer: 1.0;urothelial cancer: 1.9"	"Region enriched"	"Detected in some"	4	"cerebral cortex: 4.2"	"Group enriched"	"Detected in many"	6	"basophil: 58.6;neutrophil: 177.2;non-classical monocyte: 84.4"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.2;monocytes: 84.4"	"Cell line enriched"	"Detected in some"	4	"RT4: 37.1"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	5.7	0.1	0.0	9.2	0.0	27.6	2.3	0.0	4.2	1.4	0.3	0.5	0.2	0.0	0.5	16.9	0.8	0.7	0.5	0.1	0.0	0.9	1.8	8.3	0.4	0.1	0.1	0.0	0.1	0.0	3.4	0.2	1.9	1.0	1.5	0.1	0.1	3.5	2.7	0.1	15.0	0.2	0.2	0.0	19.8	0.4	0.1	0.1	4.0	0.4	1.1	7.8	7.2	4.4	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	9.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	58.6	2.2	0.8	0.0	16.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	177.2	0.0	84.4	0.0	0.0	2.9	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.1	0.2	0.1	3.2	6.7	0.0	0.7	94.4	81.1	57.3	159.4	0.2	0.7	0.3	0.0	0.0	24.6	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	21.5	1.4	0.0	0.1	3.8	0.0	0.0	0.1	6.0	0.0	0.0	0.0	12.2	10.6	57.4	0.2	0.0	20.1	8.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.7	0.0	0.1	2.2	0.2	0.0	0.0	1.4	0.1	0.0	66.9	106.3	13.8	1.0	0.0	0.0	66.1
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67398724	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;placenta: 7.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.4;Excitatory neurons: 22.5;Inhibitory neurons: 16.6;T-cells: 12.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 2.5;melanoma: 5.6;renal cancer: 1.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 4.6"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 21.3"	"Group enriched"	"Detected in many"	35	"NK-cells: 21.3;T-cells: 6.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 4.6;SCLC-21H: 6.8;SK-MEL-30: 18.4;THP-1: 13.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.4"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	1.9	0.3	0.7	1.2	1.8	0.8	0.4	0.0	2.5	0.6	1.5	0.4	0.3	0.2	0.3	0.8	0.1	0.5	0.2	4.6	0.6	0.3	0.8	0.4	1.8	0.2	1.0	1.2	0.2	2.6	0.8	0.0	7.0	0.5	0.1	0.4	0.1	1.3	0.7	3.6	1.4	0.4	0.4	0.0	1.4	0.3	1.0	0.3	1.0	0.1	0.7	0.9	0.7	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.3	0.0	0.1	18.4	0.0	0.0	13.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	6.0	0.0	3.2	0.0	1.6	1.0	0.0	0.0	0.0	0.1	0.3	21.3	0.0	0.0	3.9	1.2	0.7	1.8	0.0	2.5	4.6	0.6	0.2	1.0	1.2	0.5	0.0	0.3	1.1	0.2	0.0	2.3	1.0	0.6	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.7	0.0	0.7	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.5	0.3	0.3	0.1	0.0	0.8	22.5	0.0	0.0	0.9	2.6	0.7	0.0	1.5	0.0	0.0	3.8	0.0	16.6	0.0	0.0	0.8	0.9	0.9	0.0	0.5	1.8	2.8	0.0	0.0	4.1	1.0	1.6	0.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.0	0.6	0.0	12.8	0.0	0.0	0.1
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.5;urinary bladder: 4.5"	"Group enriched"	"Detected in some"	5	"granulocytes: 4.5;T-cells: 2.7"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.7;urothelial cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.8;granulocytes: 3.4;T-cells: 1.4"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 247.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"	NA	NA					"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.90e-7)"	0.1	0.0	0.2	1.0	0.2	0.5	0.2	0.1	0.2	0.2	0.0	0.4	0.6	0.2	0.1	0.5	0.3	0.8	0.0	0.2	0.1	0.1	0.2	1.1	2.4	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.4	0.1	0.1	0.5	1.7	0.1	0.1	1.7	0.7	0.0	0.1	3.5	0.3	0.0	2.2	4.5	0.2	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.3	23.8	0.0	0.0	0.0	0.5	247.8	0.0	0.2	0.0	0.0	0.0	0.0	5.6	3.7	0.8	0.0	1.1	9.5	4.9	0.0	0.1	0.0	0.6	0.1	0.0	0.0	19.2	0.2	0.1	0.0	0.4	0.2	0.0	0.3	0.4	0.0	0.1	0.6	0.1	0.1	1.2	0.6	0.9	0.2	0.3	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.8	0.3	0.6	0.0	1.8	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.1	2.1	0.2	1.1	0.3	0.1	0.1	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.2	0.3	3.6	0.4	0.7	2.3	0.3	0.2	0.1	0.0	0.1	13.8	1.0	0.1	0.2	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.3	5.2	2.0	0.0	1.3	1.6	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.1	0.2	0.1	0.1	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51055626-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"esophagus: 524.0"	"Group enriched"	"Detected in some"	4	"Late spermatids: 246.9;Squamous epithelial cells: 68.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 20.6;head and neck cancer: 42.3;melanoma: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062136	Enhanced				"Secreted in other tissues"	NA	NA					"HPA062136: AB_2684694"	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.2	46.1	0.7	0.6	1.6	0.5	0.4	524.0	0.5	1.2	0.2	0.1	0.1	0.1	0.2	0.7	0.0	0.1	0.1	0.0	0.2	4.4	0.4	0.3	0.0	0.1	0.6	0.1	0.0	75.5	0.0	0.1	10.9	0.8	0.3	0.1	0.1	1.4	4.4	0.2	0.2	0.3	0.0	64.1	0.2	123.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	27.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.6	1.1	4.0	0.0	0.9	1.9	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.1	0.1	0.3	1.8	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	246.9	0.3	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.7	68.3	1.3	0.0	0.4	0.4	0.0	2.1
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703752	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 179.4;lymphoid tissue: 76.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0"	"Group enriched"	"Detected in some"	4	"cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 7.0"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Low region specificity"	"Detected in some"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"		No	NA		300000000	"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	8.0	0.0	0.1	16.8	179.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	5.9	0.2	2.3	1.6	0.0	0.0	0.3	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	76.9	2.6	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.2	4.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5912.0;skin 1: 5932.7;vagina: 2168.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.1	1.7	0.3	1.8	0.9	4.7	255.2	0.7	0.7	408.5	47.2	1.7	0.0	2.1	98.1	5912.0	12.6	2.0	3.5	1.8	0.3	1.3	3.5	6.4	3.1	0.2	0.2	0.2	2.2	4.7	0.1	8.3	2.0	0.3	126.9	0.1	0.0	887.4	101.0	10.0	5932.7	1.8	0.6	0.1	1.8	5.1	2.1	0.7	531.9	3.0	0.3	654.1	94.1	2168.5	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.3	0.9	0.7	0.7	1.8	0.3	0.2	0.2	0.2	0.3	0.1	0.7	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 267.9"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	2.2	0.1	0.1	0.0	0.7	0.7	0.0	0.3	1.1	267.9	0.0	0.2	0.0	1.3	0.0	0.2	0.4	0.0	1.0	2.0	0.1	0.3	0.3	0.0	0.2	0.2	0.0	0.0	1.3	0.4	1.4	0.3	0.0	1.6	0.0	0.0	0.0	0.8	0.2	0.0	0.0	2.9	0.5	1.8	0.6	0.0	0.2	0.7	4.5	3.2	0.2	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.7	0.2	0.4	0.3	0.3	0.0	0.4	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"NCCRP1, F-box associated domain containing"	Q6ZVX7	19	39196964-39201884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 457.0;lymphoid tissue: 126.0;skin 1: 257.3;vagina: 183.2"	"Cell type enriched"	"Detected in some"	12	"monocytes: 563.9"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 30.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.6"	"Low region specificity"	"Detected in some"			HPA052812	Approved					NA	NA		400000			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.3	0.2	1.8	2.1	1.1	1.0	6.3	1.8	1.9	46.5	0.0	0.4	2.0	0.6	0.8	457.0	1.1	0.8	0.4	1.2	1.0	2.8	0.2	0.4	2.8	1.2	1.1	0.8	0.4	8.9	1.4	0.4	1.1	1.6	1.4	1.9	1.7	54.4	1.2	0.9	257.3	0.7	0.5	0.9	1.4	0.5	0.5	1.1	4.2	0.6	0.0	126.0	5.2	183.2	1.6	0.2	0.2	1.1	0.2	0.1	0.7	2.4	0.1	0.0	0.1	0.2	0.5	0.5	0.7	2.3	0.4	0.2	1.0	1.7	0.7	0.5	0.0	0.4	0.2	0.9	0.1	0.2	0.5	0.3	0.5	0.5	0.1	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.2	0.2	0.7	0.2	0.2	0.2	0.4	0.4	0.1	0.6	0.6	1.0	2.9	30.8	0.2	0.9	0.4	0.9	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.5	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	1.8	1.1	1.8	1.9	1.2	1.0	1.2	1.1	0.8	1.6	0.9	1.1	1.6	0.0	0.0	0.0	0.0	0.0	0.6	1.6	8.5	0.0	0.3	4.7	2.4	0.3	0.0	30.8	3.7	0.0	0.4	0.2	0.1	0.0	2.7	0.0	0.7	0.4	0.2	0.0	0.0	0.0	2.3	3.1	1.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	4.7	0.2	0.0	0.7	1.8	0.0	563.9	0.3	0.0	0.0	0.0	4.2	0.7	0.0	1.2	1.1	0.0	0.1	1.6	0.0	0.0	0.1	2.0	0.1	0.5	7.3	7.1	11.1	0.2	0.1	0.0	46.4
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"esophagus: 420.0;skin 1: 705.5;vagina: 202.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 139.7;Squamous epithelial cells: 234.5;Suprabasal keratinocytes: 409.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 125.5;head and neck cancer: 295.4;lung cancer: 79.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 234.6;HBEC3-KT: 144.2;hTCEpi: 501.4;hTERT-HME1: 132.5;PC-3: 192.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		2500000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	9.8	0.2	0.2	0.2	0.3	0.2	32.1	0.0	0.9	49.4	0.0	0.3	0.2	0.2	3.3	420.0	1.0	0.1	0.5	0.1	0.1	0.4	0.3	5.0	0.2	0.0	0.3	0.3	0.2	0.5	0.0	0.6	5.6	0.3	32.6	0.2	32.7	61.0	9.2	6.7	705.5	0.7	0.0	0.0	0.1	0.4	0.2	0.1	23.9	0.5	2.9	48.4	3.2	202.1	0.3	49.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	1.1	0.0	0.2	0.1	0.0	234.6	0.0	144.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	501.4	5.6	132.5	0.0	0.0	0.1	0.0	0.2	0.0	38.4	0.0	0.1	0.0	0.0	192.6	0.0	0.4	0.0	0.0	1.1	0.0	0.0	18.3	4.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.9	0.1	0.1	0.0	0.3	0.3	0.3	0.0	0.1	0.3	39.9	0.0	0.0	0.3	0.0	139.7	58.2	57.1	63.7	34.7	7.7	17.9	1.9	0.0	20.0	0.0	2.1	0.1	0.1	0.1	0.0	2.5	0.1	0.2	0.1	4.1	0.0	0.0	0.6	1.1	0.1	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.1	1.6	4.1	0.0	16.5	0.8	0.0	0.4	16.0	0.0	0.0	5.2	0.0	0.0	0.1	16.1	0.1	0.0	0.0	25.7	0.2	0.1	2.8	37.4	0.0	6.1	2.0	0.0	0.1	234.5	409.0	0.1	1.1	0.0	0.1	47.5
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094562	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"prostate: 19.3;skin 1: 16.1;vagina: 22.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RPMI-8226: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074206			Approved	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA074206: "	"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	2.5	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	19.3	0.0	0.2	0.8	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	22.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	15.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.4
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.1	1.5	1.5	0.2	5.7	0.0	0.3	1.0	10.3	0.1	0.2	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	9.4	2.2	0.0	0.0	0.0	1.0	2.0	2.4	2.7	0.1	0.1	0.2	0.0	0.0	3.4	0.2	0.0	0.3	0.3	0.1	0.9	32.9	0.0	0.0	0.5	0.1	0.1	0.8	1.9	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.7	1.0	10.3	9.4	2.2	2.0	2.4	2.7	3.4	0.5	1.9	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520388-232525716	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 3.1;retina: 5.3;skeletal muscle: 9.8"	"Group enriched"	"Detected in some"	10	"Early spermatids: 29.0;Muller glia cells: 45.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.2;colorectal cancer: 2.5;endometrial cancer: 1.4;melanoma: 2.1;urothelial cancer: 4.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Daudi: 1.0"	"Group enriched"	"Detected in some"	10	"basal ganglia: 1.8;olfactory bulb: 4.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 14.9"							NA	NA								"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.0	0.0	1.0	0.0	0.8	0.0	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	2.8	1.2	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	5.3	0.0	0.0	9.8	0.0	0.0	0.0	1.0	0.0	0.0	0.8	1.2	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	1.6	3.1	0.1	2.4	2.8	1.2	0.2	3.1	1.0	1.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	45.8	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	3.6	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.5;esophagus: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3"									"HPA062673, HPA066741"			Supported	"Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Vesicles, Plasma membrane"		"HPA062673: , HPA066741: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	1.5	8.5	0.6	0.4	0.6	0.0	0.6	0.1	0.7	2.3	0.0	0.2	0.1	0.3	0.7	15.2	0.6	0.7	0.4	0.5	0.3	0.5	0.1	0.5	0.1	1.0	0.6	0.4	0.7	0.1	0.2	0.3	0.1	0.6	0.7	0.1	0.1	3.7	1.0	0.2	2.7	0.2	0.6	0.1	0.1	0.4	0.3	0.6	0.0	0.5	0.1	1.1	1.8	6.1	0.3	1.0	1.4	0.0	1.7	2.3	1.7	0.0	0.8	3.0	1.3	1.9	0.0	1.5	0.0	0.6	1.7	1.4	2.7	0.9	5.3	1.1	0.3	1.6	0.5	29.5	0.0	0.7	0.0	0.0	3.3	22.6	3.5	1.7	1.5	0.3	0.7	0.3	0.2	0.6	1.3	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	1.0	3.2	0.3	0.3	11.9	0.5	0.0	0.1	0.4	0.4	1.6	0.6	0.5	1.6	0.8	0.0	0.0	0.0	9.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.1	0.7	0.5	0.3	1.0	0.6	0.4	0.6	0.1	0.6	0.3	1.4	0.0	0.0	0.0	0.0	3.1	5.1	42.9	2.8	0.0	0.4	0.4	0.1	1.5	14.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.4	0.1	1.3	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.7	0.1	0.9	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.2	1.1	0.0	0.3	8.9	1.7	0.1	0.3	0.5	0.0	8.1
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 58.5;vagina: 17.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.4;Basal prostatic cells: 11.3;Basal respiratory cells: 6.4;Prostatic glandular cells: 7.1;Squamous epithelial cells: 7.2;Suprabasal keratinocytes: 17.0;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.8;head and neck cancer: 10.1;lung cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 14.3"									HPA066741			Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA066741: "	"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavorable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	58.5	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.3	0.3	17.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.2	0.0	0.7	14.3	0.3	0.4	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	2.6	0.7	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	11.3	6.4	1.2	0.0	0.4	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.8	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.1	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.0	0.1	7.2	17.0	0.0	0.0	0.0	0.1	8.1
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661893	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 817.2;vagina: 675.1"	"Group enriched"	"Detected in some"	6	"Basal respiratory cells: 6903.4;Club cells: 6726.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 186.5;head and neck cancer: 69.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;HaCaT: 6.5;HBEC3-KT: 1.6;SiHa: 4.1;U-2197: 8.2"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		9100000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.1	0.1	0.0	0.3	0.0	0.0	1.1	0.0	0.0	203.5	0.0	0.1	0.0	3.3	0.0	817.2	0.2	0.2	0.4	0.0	0.0	0.1	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.0	7.6	0.0	0.0	100.8	0.0	0.1	43.3	0.1	0.0	0.0	0.1	0.5	1.9	0.0	4.8	0.1	0.0	19.8	74.4	675.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	6.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	35.2	6903.4	2.2	0.0	0.0	0.0	0.0	0.0	6726.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	31.4	0.1	0.2	0.5	0.0	0.0	0.0	8.9	0.0	3.0	0.0	0.9	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	986.7	0.0	0.0	55.4	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	60.2	0.0	0.2	447.6	0.0	0.0	0.0	178.1	1.0	0.3	413.5	0.0	0.3	0.8	0.0	0.0	265.9
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 18.9;prostate: 12.3;seminal vesicle: 33.5;skin 1: 36.6;vagina: 14.2"	"Cell type enhanced"	"Detected in some"		"Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	71	"HaCaT: 23.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.0	0.2	0.1	0.2	0.0	2.0	0.2	0.3	4.2	0.2	1.9	0.0	0.3	0.1	18.9	0.5	0.4	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.3	0.2	0.2	0.0	0.0	2.3	0.1	0.3	0.2	12.3	1.3	3.7	4.2	33.5	0.2	36.6	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	2.8	0.3	14.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	0.0	0.2	0.8	0.3	0.4	0.0	0.7	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	12.0	6.0	0.3	0.0	0.0	1.4	4.4
SPANXB1	"CT11.2, SPANXB2, SPANXF1, SPANXF2"	ENSG00000227234	"SPANX family member B1"	Q9NS25	X	141002594-141003706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 89.5"	"Group enriched"	"Detected in some"	160	"Early spermatids: 686.8;Late spermatids: 2015.4"	"Group enriched"	"Detected in some"	4	"breast cancer: 2.1;cervical cancer: 1.1;head and neck cancer: 2.1;lung cancer: 1.8;urothelial cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 81.9;GAMG: 16.6;U-2 OS: 27.4"									"HPA046423, HPA073647"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA046423: AB_2679660, HPA073647: AB_2732232"															"unprognostic (8.55e-2)"			0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	81.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	16.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	27.4	1.9	0.7	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	686.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2015.4	6.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	6.6	0.0	0.1	8.4	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 19659.3;vagina: 6111.4"	"Cell type enriched"	"Detected in some"	11	"Squamous epithelial cells: 987.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 206.3;head and neck cancer: 423.4;stomach cancer: 113.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.5;CAPAN-2: 5.8;hTCEpi: 9.7;OE19: 4.4;RT4: 12.6;TIME: 3.4"	"Not detected"	"Not detected"							HPA044467	Enhanced					NA	NA		5200			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	3.7	3.5	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2034.4	0.0	2.4	0.1	3.5	0.0	19659.3	3.4	38.5	7.4	0.0	0.0	2.5	5.8	1.7	0.0	0.0	0.1	0.0	4.4	8.8	0.0	11.1	0.7	0.0	3.4	0.1	0.0	3182.9	0.0	5.0	5.2	4.3	1.7	0.0	3.4	15.3	2.1	0.0	1.4	2.3	0.0	2420.4	65.8	6111.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	5.8	3.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	12.6	0.0	0.0	0.3	2.7	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	7.4	0.0	0.0	0.0	0.1	0.0	41.3	0.0	0.0	5.9	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.2	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.4	0.0	0.1	2.1	0.0	0.0	0.0	1.0	0.0	0.0	987.1	0.0	7.5	0.4	0.1	0.0	89.6
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"esophagus: 719.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Basal respiratory cells: 63.6;Club cells: 18.8;Distal tubular cells: 29.4;Squamous epithelial cells: 34.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 30.8;head and neck cancer: 78.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.5;HaCaT: 24.2;HeLa: 16.2;MCF7: 17.5;SK-BR-3: 21.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171, HPA070372"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		530000	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869, HPA070372: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	12.4	1.3	0.5	0.9	0.8	0.7	2.2	3.7	2.0	38.5	0.6	1.4	0.9	1.0	1.7	719.2	4.4	0.6	3.2	0.5	0.6	2.5	1.8	5.4	1.5	1.3	1.1	0.4	3.1	3.2	0.2	3.3	1.2	2.1	4.1	0.9	1.7	90.4	4.4	1.1	73.5	1.9	0.5	0.4	2.6	1.8	2.9	0.8	1.3	2.8	0.3	40.7	1.3	145.4	1.2	1.1	2.0	1.1	1.0	0.0	0.8	17.5	0.4	0.2	1.0	1.6	1.2	1.7	1.0	2.3	1.3	0.3	24.2	2.8	2.0	0.6	2.0	3.3	1.4	16.2	5.7	0.8	0.9	1.5	1.5	9.3	0.5	2.0	0.5	0.7	3.4	1.0	1.0	0.7	17.5	0.7	1.9	0.3	1.1	2.2	1.1	0.1	1.1	0.6	2.1	1.2	1.6	0.2	21.7	0.1	1.4	1.5	1.1	0.8	1.1	4.8	2.0	0.9	1.5	1.8	0.3	0.4	2.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	3.7	2.0	0.5	0.6	1.3	1.1	0.4	2.1	0.4	0.8	1.2	0.2	12.8	1.1	2.0	0.0	0.3	4.6	63.6	4.0	0.9	1.1	0.8	0.8	5.7	18.8	0.0	0.0	1.4	0.3	0.2	29.4	2.0	0.1	0.3	0.2	0.2	0.0	0.0	1.5	0.9	0.8	3.9	0.0	0.6	4.5	0.7	0.0	0.2	0.4	0.0	1.7	0.1	6.1	0.6	0.3	0.0	0.6	0.4	0.0	1.0	0.4	0.2	0.0	1.0	1.0	2.6	0.0	0.4	0.1	7.4	0.1	0.2	2.1	0.6	0.0	0.1	1.0	0.0	0.6	34.7	1.8	1.2	0.6	1.2	0.3	6.2
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.7"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 74.6"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9"	"Region enhanced"	"Detected in single"		"thalamus: 1.8"	"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9"	"Lineage enriched"	"Detected in single"	16	"T-cells: 14.8"	"Cell line enriched"	"Detected in many"	12	"GAMG: 427.6"															NA	NA						"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	3.9	0.3	0.0	0.5	0.2	0.7	2.9	0.2	0.9	0.8	0.0	0.3	0.2	0.3	0.0	3.4	0.3	0.1	0.1	0.2	0.3	0.2	0.5	3.6	0.5	0.2	0.2	0.1	0.7	0.3	0.0	0.1	0.8	0.3	0.5	0.2	0.5	1.5	0.0	1.6	1.8	0.2	0.1	0.1	0.6	0.5	4.7	1.8	0.2	0.7	0.5	0.8	0.3	1.7	0.8	15.6	7.2	0.2	0.4	0.9	4.6	0.3	0.0	4.4	1.6	2.9	0.0	8.2	0.2	2.6	0.0	427.6	2.2	0.0	1.7	1.1	0.6	0.0	0.3	2.1	0.0	1.0	0.5	0.4	0.5	1.4	18.8	31.3	0.0	0.0	0.9	9.8	0.9	4.8	1.2	0.1	0.8	0.0	0.2	36.2	0.2	3.2	0.9	0.0	0.4	0.3	0.0	2.5	0.1	0.7	0.4	0.6	0.2	1.4	18.6	15.6	2.9	9.1	0.5	5.6	0.3	20.2	0.7	0.3	0.9	0.3	0.4	14.8	0.4	0.1	0.1	1.3	3.9	0.1	0.3	0.7	4.9	0.6	0.7	0.1	0.6	0.4	1.6	0.0	0.2	0.2	0.9	0.2	0.3	0.2	0.2	0.1	0.3	0.1	1.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	9.3	4.9	4.9	0.0	0.4	0.9	0.1	0.0	0.0
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 198.1"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	198.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.3	0.0	0.0	38.4	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.7;lymphoid tissue: 50.7;urinary bladder: 14.2"	"Group enriched"	"Detected in some"	4	"B-cells: 64.2;Early spermatids: 24.0;Late spermatids: 33.3;Plasma cells: 40.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 94.6;HDLM-2: 132.5;Karpas-707: 50.4;U-266/70: 41.7;U-266/84: 34.2;U-87 MG: 38.6"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	1.2	0.6	0.8	21.8	0.5	1.2	0.9	0.8	0.7	0.6	6.9	2.4	1.9	0.4	0.3	1.6	0.4	2.4	0.3	0.8	0.7	0.4	1.7	1.7	50.7	1.2	1.0	0.4	0.2	0.4	0.0	9.9	0.9	1.0	0.9	2.3	0.4	1.3	0.1	0.3	0.6	15.7	0.8	0.7	25.1	3.2	2.5	0.9	4.2	0.7	1.0	49.9	14.2	0.5	0.6	15.8	0.0	0.9	0.0	0.0	12.5	0.0	0.0	1.6	1.1	1.0	0.0	0.0	94.6	0.1	0.0	0.1	0.1	0.0	0.0	1.0	132.5	0.0	3.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	50.4	0.0	0.0	0.0	0.3	0.9	0.0	0.4	0.0	0.0	8.9	0.0	8.3	8.6	0.0	0.2	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.1	17.9	0.3	41.7	34.2	0.8	38.6	3.4	6.7	20.7	8.2	0.0	2.0	7.0	5.4	143.8	5.3	3.5	4.2	63.7	0.5	1.3	16.3	0.0	8.2	0.0	11.9	5.0	0.8	0.5	0.8	0.7	0.8	0.7	1.2	1.0	0.4	1.0	0.7	0.9	0.6	0.4	0.0	0.0	0.0	64.2	0.0	0.1	0.2	0.0	0.7	0.1	0.3	0.3	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.4	0.0	0.0	3.2	1.9	33.3	0.3	3.2	3.6	0.0	4.0	0.3	0.0	0.5	0.0	0.1	0.1	0.7	40.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.7	0.4	1.4	0.0	0.0	10.0	0.0	0.0	0.4
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630919-4642294	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.9;fallopian tube: 12.8"	"Group enriched"	"Detected in some"	5	"Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.6"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	193	"eosinophil: 602.9"	"Lineage enriched"	"Detected in many"	193	"granulocytes: 602.9"	"Group enriched"	"Detected in some"	7	"HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved					NA	NA					"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	16.9	0.0	0.5	1.7	1.6	0.5	3.2	0.0	1.3	0.5	0.0	1.1	1.9	0.0	0.4	0.8	12.8	0.6	1.6	0.5	0.6	0.0	0.1	6.7	1.9	1.1	0.2	0.6	0.1	0.0	0.0	3.0	0.1	0.7	0.2	1.0	0.0	0.2	0.3	0.0	2.3	3.4	0.6	0.2	1.4	1.1	1.9	0.4	0.8	0.0	0.0	0.6	1.1	0.1	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	14.7	0.0	0.3	1.1	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	602.9	0.0	0.2	0.2	0.1	0.0	0.1	3.1	0.2	0.0	0.1	0.9	0.0	0.1	2.7	0.1	0.4	0.5	1.6	0.0	1.3	0.5	0.6	1.1	0.2	0.6	0.7	0.2	0.4	0.6	0.0	0.0	1.1	0.0	0.2	1.5	0.0	13.0	0.0	0.0	1.1	0.1	0.9	11.5	60.3	0.0	0.0	1.8	1.3	0.0	0.0	0.0	19.2	3.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	3.6	0.0	0.1	1.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	4.1	0.0	72.2	2.5	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	191.8	0.0	0.0	0.1	3.9	1.2	1.2	0.0	0.9	7.4	0.3	0.0	0.0	0.3
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 196.8;skin 1: 328.0;vagina: 101.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 118.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.2;head and neck cancer: 5.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 374.5;HBEC3-KT: 485.0;hTCEpi: 140.1;SiHa: 116.6"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	18.3	0.2	0.0	0.0	0.0	1.2	22.1	0.0	0.1	22.8	0.0	0.2	0.0	0.1	0.0	196.8	6.2	0.1	1.6	0.0	0.0	0.0	1.1	16.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.2	24.3	0.0	6.8	0.0	0.0	41.1	4.6	1.1	328.0	0.1	0.0	0.0	0.1	0.3	0.8	0.0	4.3	0.1	0.0	35.4	37.7	101.3	0.0	70.1	18.2	0.0	0.0	0.0	0.0	24.8	0.9	0.1	0.0	0.0	1.9	12.6	0.0	0.6	0.3	0.5	374.5	0.0	485.0	0.0	28.9	0.0	0.0	33.3	0.0	9.3	0.0	0.7	0.0	140.1	0.2	58.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	70.2	0.2	0.7	0.0	0.0	0.8	0.0	0.0	76.0	0.1	0.0	116.6	12.0	0.0	7.2	0.0	0.7	0.0	0.1	12.2	0.1	0.3	0.0	0.1	0.0	2.8	0.1	0.2	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	1.1	0.0	0.0	0.0	3.0	0.2	11.4	1.6	2.3	2.4	3.7	18.6	19.9	0.0	0.0	14.8	0.0	3.0	0.0	0.7	0.4	1.0	0.0	0.9	0.0	0.0	0.0	0.2	11.4	12.8	5.6	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.7	1.4	0.0	1.2	2.5	5.2	0.0	10.9	0.2	13.1	0.0	1.5	0.3	2.4	118.7	1.1	6.3	0.6	0.0	0.2	5.9
C12orf54	MGC35033	ENSG00000177627	"Chromosome 12 open reading frame 54"	Q6X4T0	12	48482498-48496524	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	39	"testis: 40.7"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2541.6"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.9;head and neck cancer: 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 2.7"					"Not detected"	"Not detected"			HPA073090			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA073090: "	"unprognostic (2.59e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.94e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.99e-2)"		"unprognostic (5.96e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.37e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.92e-1)"	0.0	0.4	0.4	0.0	0.5	0.0	0.2	0.3	1.0	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.6	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.3	0.4	0.1	0.0	40.7	0.3	0.0	0.0	0.2	0.6	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	1.0	0.4	0.3	0.6	0.5	0.4	0.6	0.4	0.3	0.6	0.0	0.0	2.6	8.1	0.0	5.1	38.6	19.5	1.2	0.2	0.2	0.1	0.7	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.9	0.1	543.1	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	9.1	0.0	2.0	0.0	1.8	2541.6	10.8	1.4	0.0	2.8	0.0	0.3	0.0	4.5	2.5	0.0	0.0	13.2	0.0	6.4	0.0	1.9	1.9	0.2	6.6	4.3	1.0	11.5	6.5	5.9	2.3	0.0	0.5	0.4	0.0	10.8
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524961-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 511.2;skin 1: 152.9;vagina: 202.4"	"Cell type enriched"	"Detected in some"	8	"Squamous epithelial cells: 1257.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 150.9;head and neck cancer: 196.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0"	"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					NA	NA		1200000			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.3	0.1	0.2	0.0	0.1	0.0	5.4	1.5	0.1	51.5	0.0	0.1	0.0	0.1	0.1	511.2	1.2	0.0	0.1	0.0	0.4	17.5	1.6	0.0	0.0	0.5	0.4	0.0	0.1	0.2	0.0	0.3	0.0	0.2	3.0	0.0	0.0	121.9	0.1	1.1	152.9	0.2	0.0	0.0	0.1	0.3	1.7	0.6	80.2	0.1	0.0	40.2	0.2	202.4	0.0	21.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.1	0.0	0.4	0.5	0.4	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	28.4	29.8	6.3	157.1	2.2	13.3	22.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	4.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	28.5	0.0	1.4	8.3	0.3	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	59.6	0.7	0.3	0.0	0.0	0.9	6.7	0.1	1257.1	55.0	0.0	0.7	0.0	0.2	30.6
CAPN14		ENSG00000214711	"Calpain 14"	A8MX76	2	31173056-31233858	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"esophagus: 145.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.2;Inhibitory neurons: 4.2;Squamous epithelial cells: 8.2;Urothelial cells: 15.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.9;head and neck cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.1;U-266/70: 3.4"					"Not detected"	"Not detected"									NA	NA						"unprognostic (5.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.71e-4)"	"unprognostic (8.42e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.47e-4)"	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.6	0.8	0.1	0.0	1.7	0.0	0.7	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.6	0.8	0.1	0.2	0.0	0.0	3.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	1.7	4.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.5	0.5	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	8.2	0.0	1.4	0.1	0.0	0.1	15.5
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049480-15058293	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skin 1: 489.9"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 96.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 49.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		3600000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.3	0.0	0.1	0.0	0.3	0.4	7.9	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.8	0.0	0.1	1.1	4.3	1.4	489.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.0	0.0	0.0	0.0	0.0	20.0	0.9	1.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	19.1	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	96.0	0.7	0.1	0.0	0.0	0.8
CCDC177	"C14orf162, PLPL"	ENSG00000267909	"Coiled-coil domain containing 177"	Q9NQR7	14	69569799-69574871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 5.5;retina: 4.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 14.7;Cone photoreceptor cells: 10.4;Horizontal cells: 5.0;Rod photoreceptor cells: 9.0"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.21e-1)"	"unprognostic (2.33e-2)"		"unprognostic (6.94e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-3)"	"unprognostic (6.34e-4)"	"unprognostic (2.58e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.84e-5)"	"unprognostic (2.15e-4)"	"unprognostic (3.81e-1)"		"unprognostic (1.45e-1)"	0.0	0.1	0.6	0.0	0.7	0.0	0.1	5.5	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.4	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	5.5	2.6	1.9	0.4	0.0	0.1	1.1	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.1	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CCDC60	MGC39827	ENSG00000183273	"Coiled-coil domain containing 60"	Q8IWA6	12	119334712-119541040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 19.0;fallopian tube: 18.4;testis: 11.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 28.6;Early spermatids: 155.1;Late spermatids: 74.7;Respiratory ciliated cells: 43.7;Urothelial cells: 32.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-3)"		"unprognostic (1.00e-1)"		"unprognostic (2.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.92e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.54e-1)"	0.0	0.0	5.0	0.5	1.1	0.0	0.0	1.0	0.8	5.6	19.0	1.7	0.1	0.4	0.6	1.7	18.4	0.0	0.0	0.8	2.6	0.0	0.0	1.3	0.0	4.3	2.9	0.2	0.0	0.0	0.0	0.0	0.5	3.0	3.1	4.6	2.5	1.1	1.6	0.1	0.0	0.1	0.0	4.9	0.0	0.3	11.7	2.0	0.1	0.0	0.0	2.3	3.2	2.4	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.1	1.0	0.8	0.8	2.6	4.3	2.9	0.2	3.0	4.9	2.0	1.5	0.0	0.0	0.0	1.6	0.2	0.8	28.6	3.1	8.6	0.3	0.0	0.0	0.3	0.0	4.7	0.0	14.6	0.0	0.0	0.3	0.0	0.1	155.1	19.4	0.2	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.1	10.2	0.0	0.0	74.7	0.9	0.1	0.0	2.8	0.0	0.2	0.0	0.0	1.0	0.1	0.5	0.4	0.0	5.5	0.1	0.0	43.7	1.0	0.0	0.0	1.2	23.1	2.3	5.9	0.0	0.0	0.0	0.1	0.7	32.9
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 26.5;pituitary gland: 34.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.2	7.1	1.7	7.4	1.3	3.1	5.5	8.0	1.0	26.5	1.7	0.8	0.7	1.0	7.4	2.3	0.5	0.6	6.3	7.3	0.4	0.8	2.3	2.2	7.3	5.7	5.8	0.8	1.5	2.1	34.0	2.6	7.9	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	5.9	5.5	3.9	14.9	6.0	2.1	1.3	0.0	2.6	2.4	2.4	8.3	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.1	7.4	5.5	8.0	6.3	7.3	7.3	5.7	5.8	7.9	5.9	6.0	8.3	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 376.9;intestine: 260.2"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	14.0	9.1	0.0	2.2	6.8	8.1	21.4	3.4	260.2	0.1	0.1	0.1	376.9	0.2	0.2	0.1	6.1	6.6	0.1	0.1	0.0	0.0	9.3	7.5	5.3	0.0	0.1	0.0	0.5	0.0	8.5	2.5	144.9	0.0	23.3	0.2	0.1	17.3	29.3	3.0	7.0	0.1	0.6	0.3	7.4	0.1	0.0	0.0	30.3	100.3	67.4	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.1	6.8	8.1	6.1	6.6	9.3	7.5	5.3	8.5	7.0	7.4	13.1	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLEC2A	"INPE5792, KACL, PILAR, UNQ5792"	ENSG00000188393	"C-type lectin domain family 2 member A"	Q6UVW9	12	9898673-9932370	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 58.0"	"Group enriched"	"Detected in some"	11	"Basal keratinocytes: 18.7;Suprabasal keratinocytes: 37.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 22.0;U-937: 54.6"									"HPA048530, HPA072407"	Approved		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA048530: AB_2680429, HPA072407: AB_2686518"		"unprognostic (3.10e-1)"							"unprognostic (5.29e-2)"						"unprognostic (2.23e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	3.6	1.9	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.2	58.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.2	0.1	0.3	0.4	0.2	0.0	0.9	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	37.1	0.0	0.1	0.0	0.0	0.1
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852369-9869386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;dendritic cells: 255.7;NK-cells: 265.7;Suprabasal keratinocytes: 240.8;T-cells: 276.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 221.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.7;ASC TERT1: 87.7;fHDF/TERT166: 49.5;HSkMC: 50.3;U-937: 229.5"					"Low region specificity"	"Detected in all"			HPA008194	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	32.3	7.5	10.2	22.1	10.0	114.0	23.7	11.9	20.2	22.8	12.0	9.5	7.2	20.1	6.6	17.6	15.6	20.6	13.4	9.7	9.8	8.1	16.5	39.7	32.5	11.5	9.6	8.8	33.4	2.5	2.9	4.2	17.8	11.3	9.9	13.7	2.4	12.8	6.1	17.3	80.6	14.1	14.6	10.0	45.0	9.2	3.0	11.8	16.4	10.5	20.8	16.1	20.0	24.1	12.4	0.3	2.6	0.0	0.2	56.7	87.7	0.4	1.6	11.0	0.8	2.9	0.1	1.8	1.2	0.9	49.5	32.8	17.4	8.0	0.1	0.2	1.8	0.1	2.3	0.1	0.1	19.9	2.0	0.4	50.3	18.1	2.2	0.4	2.9	29.1	9.0	0.1	7.4	13.0	0.1	15.2	4.1	0.3	0.0	2.0	20.9	0.4	0.1	0.1	18.3	0.1	0.0	0.8	0.2	13.9	0.2	3.6	0.6	41.8	0.4	9.2	1.6	5.3	13.2	1.2	1.7	13.5	229.5	16.8	54.8	37.8	14.6	68.2	58.1	55.4	12.6	42.3	69.7	34.5	20.0	40.2	62.2	221.4	67.2	75.6	12.6	36.0	84.4	10.2	10.0	11.9	20.2	9.7	9.8	11.5	9.6	8.8	11.3	10.0	11.8	12.4	216.3	3.2	23.1	0.0	102.0	201.6	76.4	393.1	106.4	0.1	4.4	7.7	3.6	7.2	122.3	0.0	0.0	0.9	255.7	0.5	0.0	5.1	0.3	5.8	84.2	179.5	1.8	32.8	0.0	0.8	2.0	97.1	3.6	5.5	54.4	1.3	142.8	3.6	74.4	0.0	0.0	1.0	61.1	141.5	208.2	2.4	49.7	183.2	80.0	15.0	59.2	1.1	265.7	0.0	0.2	1.9	0.0	17.7	102.8	23.9	0.3	1.1	17.4	0.7	6.6	45.8	26.4	0.3	0.5	99.9	240.8	1.9	276.6	16.7	1.1	140.9
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.8;skin 1: 57.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 17.7;Basal respiratory cells: 23.7;Exocrine glandular cells: 54.1;Fibroblasts: 11.5;Suprabasal keratinocytes: 31.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 140.1;hTERT-RPE1: 261.0;LHCN-M2: 284.2;U-2 OS: 151.0;U-87 MG: 272.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		390000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.5	4.4	0.4	0.4	0.6	0.1	3.6	0.5	1.4	7.3	0.5	0.0	0.0	0.2	0.3	21.8	0.4	0.1	0.6	0.6	1.3	0.6	0.1	0.4	0.3	1.1	0.6	0.4	0.1	12.9	0.0	0.5	2.0	1.0	0.2	0.0	0.2	6.8	0.0	0.3	57.5	0.2	0.8	0.8	3.3	0.4	0.4	1.0	0.8	0.0	0.0	0.9	0.0	12.7	1.1	95.3	5.0	0.3	0.3	0.7	1.5	0.1	74.6	140.1	74.9	18.5	0.7	8.1	0.1	14.3	31.9	75.2	5.5	0.0	41.3	76.7	0.4	0.3	0.0	33.3	2.1	1.8	0.3	0.2	1.0	65.2	6.7	9.4	261.0	0.3	0.1	0.0	0.2	284.2	0.2	0.0	0.0	0.8	0.4	11.1	0.3	75.4	0.1	34.5	4.0	0.2	0.0	49.9	23.3	0.5	28.0	0.5	0.4	57.3	18.1	151.0	6.2	7.4	0.2	0.2	0.1	272.7	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.5	1.4	0.6	1.3	1.1	0.6	0.4	1.0	0.8	1.0	1.1	0.0	3.2	0.5	0.0	0.0	17.7	0.5	23.7	0.6	0.0	4.2	2.8	0.3	0.0	8.5	0.0	0.0	5.6	0.1	0.0	0.0	0.5	0.4	0.4	0.2	0.3	0.0	0.0	0.4	54.1	1.2	11.5	0.0	2.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.2	0.0	0.3	3.6	1.0	0.6	0.0	0.0	0.0	0.5	7.9	0.0	0.0	0.0	0.9	0.0	0.1	2.9	0.0	0.0	1.3	0.4	0.1	0.7	10.0	31.0	9.4	0.1	0.0	0.0	1.6
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325248-122341969	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 5960.3;vagina: 1868.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 227.7;head and neck cancer: 405.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7"	"Group enriched"	"Detected in all"	193	"dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		28000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favorable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	31.0	4.8	0.8	27.3	1.0	300.4	56.9	0.9	3.7	460.5	1.5	3.9	1.1	2.2	10.4	5960.3	4.7	7.3	4.5	0.7	1.3	2.3	39.2	26.3	25.3	1.4	0.9	0.7	21.3	3.7	0.8	5.1	19.1	1.2	19.8	3.6	0.3	1004.0	9.6	4.6	372.1	5.9	6.3	1.0	20.5	30.6	1.3	1.2	46.9	2.7	2.9	949.1	39.4	1868.5	1.4	14.6	1.3	0.2	3.2	31.5	58.0	2.9	0.6	0.8	0.0	0.0	0.0	0.0	3.2	7.6	5.9	0.5	86.9	0.0	282.0	0.0	0.3	0.2	0.7	0.0	6.8	6.8	117.6	1.9	30.5	1218.6	2.9	119.1	0.0	0.0	1.5	0.8	29.9	0.5	0.8	0.2	108.3	0.0	0.5	0.0	0.0	0.9	0.0	0.0	141.3	0.0	0.0	14.1	7.5	10.4	0.1	1.6	789.0	0.5	1.7	19.7	0.2	0.9	0.0	1.7	504.5	26.4	250.3	0.3	8.8	514.7	16.4	0.6	269.1	1.5	1.5	0.7	0.6	382.9	0.5	0.5	0.7	245.6	1.9	161.7	6.9	1.0	283.2	0.8	1.0	0.9	3.7	0.7	1.3	1.4	0.9	0.7	1.2	1.0	1.2	1.4	1.1	6.4	19.8	0.0	5.0	83.5	136.5	2493.8	117.8	0.0	7.1	119.8	0.2	2.8	768.0	0.0	0.0	230.6	7.4	3.9	0.0	2.1	0.4	0.3	0.4	3.0	0.0	3.8	0.1	22.1	17.8	13.6	12.8	0.3	13.9	0.1	6.1	96.0	134.5	0.0	0.1	0.5	179.0	579.4	90.6	2.4	10.2	243.7	8.8	0.0	1298.6	0.0	20.6	0.5	0.2	46.2	1.5	3.8	2.8	30.2	0.0	0.7	115.7	0.0	32.9	8.8	24.3	0.1	0.5	3020.6	205.0	334.2	4.9	26.1	2.0	134.1
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428278-42442946	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 121.5;lung: 150.3;salivary gland: 146.8;stomach 1: 361.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 513.8;Basal respiratory cells: 988.1;Club cells: 1743.3;Respiratory ciliated cells: 383.0;Urothelial cells: 1584.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 170.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 8.7;RT4: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	2.3	0.2	0.1	19.4	0.0	0.4	0.7	1.0	22.5	121.5	27.3	6.6	0.1	0.1	0.0	0.2	0.1	150.3	0.0	0.0	0.0	0.0	0.3	43.3	0.0	0.6	0.0	0.1	8.3	0.0	0.0	146.8	0.4	0.0	0.2	0.0	0.1	0.0	0.2	361.8	0.1	0.0	1.1	0.5	0.0	24.4	48.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	35.3	513.8	0.3	0.1	0.0	225.5	988.1	1.2	0.4	21.5	10.3	0.0	4.3	1743.3	5.5	0.0	0.0	0.2	0.2	0.0	8.7	0.4	3.0	0.6	3.5	0.0	0.0	1.5	187.4	0.0	4.3	302.2	8.4	16.4	0.1	0.0	0.0	0.0	0.0	1.2	0.0	227.9	0.0	0.0	1.5	0.0	3.9	0.0	0.0	2.6	0.2	0.0	0.5	0.5	339.6	0.0	0.0	0.5	221.2	0.0	0.2	383.0	0.6	0.0	0.0	67.6	0.1	0.6	91.6	0.0	0.0	2.4	0.0	0.2	1584.1
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056739	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	767	"intestine: 9841.1"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 1740.2;Undifferentiated cells: 1753.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 28.3;NB-4: 24.2;RPMI-8226: 26.6;SH-SY5Y: 19.6;U-2197: 8.5"									"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"	Yes	NA		110000	Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favorable (9.44e-5)"											"unprognostic (3.91e-2)"				0.2	0.4	0.1	12.8	0.1	0.3	0.5	0.1	0.5	0.0	0.1	36.6	5232.0	3.9	0.1	0.8	0.0	0.0	0.4	0.1	0.1	0.2	1.1	0.4	6.0	0.1	0.2	0.1	0.4	0.8	0.0	1.1	0.0	0.2	0.7	0.2	0.2	0.7	0.0	0.3	0.3	9841.1	0.1	0.1	0.4	1.0	0.8	0.2	0.4	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	2.5	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	325.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	399.9	0.0	0.0	0.0	1740.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	1753.0	0.0
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30989365-31042815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 100.1;skin 1: 375.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 500.7;Basal squamous epithelial cells: 214.5;Squamous epithelial cells: 419.6;Suprabasal keratinocytes: 688.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 246.2;HBEC3-KT: 54.6;hTCEpi: 156.7;hTERT-HME1: 103.6;REH: 44.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.3"					"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		6000000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	2.5	0.1	0.1	0.5	0.0	0.2	12.7	0.1	0.1	11.6	0.0	0.3	0.4	0.1	1.2	100.1	1.4	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.4	0.2	3.4	0.2	12.6	0.0	6.1	0.1	0.1	19.7	1.3	1.0	375.6	0.3	0.5	0.0	0.0	0.1	0.1	0.0	7.7	0.1	0.0	24.9	3.6	48.8	0.1	17.2	1.8	0.2	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	246.2	0.0	54.6	0.0	0.1	14.6	0.9	4.7	0.4	9.7	0.1	0.2	10.2	156.7	0.0	103.6	19.6	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.9	0.1	21.8	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	1.1	0.3	0.0	500.7	62.0	49.5	214.5	0.0	3.1	8.0	1.3	0.0	30.3	0.0	0.0	73.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.3	2.4	0.0	0.3	0.0	14.2	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.3	0.0	0.3	0.2	12.2	0.0	34.8	0.0	0.0	0.6	39.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	32.1	0.0	0.1	10.2	0.0	0.0	0.0	3.4	0.1	0.1	419.6	688.8	25.0	2.3	0.0	0.1	89.1
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447741-31478702	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 316.4;lymphoid tissue: 73.3;vagina: 120.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 197.6;Basal squamous epithelial cells: 101.9;Squamous epithelial cells: 470.6;Suprabasal keratinocytes: 206.4;Urothelial cells: 87.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.0;head and neck cancer: 183.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	53	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.2"	"Group enriched"	"Detected in some"	7	"HaCaT: 204.4;hTCEpi: 494.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046864, HPA056863, CAB069880"	Enhanced					NA	NA		190000			"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.90e-4)"	0.2	0.0	0.1	0.2	0.1	0.2	3.9	0.1	0.2	34.0	0.1	0.0	5.5	0.0	0.0	316.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.0	44.0	0.0	0.1	36.0	4.0	0.0	0.0	0.0	0.2	0.1	0.1	15.0	0.0	0.0	73.3	1.2	120.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	204.4	0.0	46.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	494.7	0.0	49.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.2	28.9	18.5	0.0	0.2	197.6	17.4	32.2	101.9	0.3	0.5	5.0	0.3	0.0	21.1	0.0	0.0	0.4	1.5	0.2	0.0	0.2	0.6	0.1	0.3	2.7	0.0	0.0	2.7	0.4	0.4	2.2	0.0	0.1	12.6	0.0	0.4	0.3	0.4	0.0	0.1	1.3	2.0	0.3	7.7	0.5	0.0	3.2	7.2	0.0	0.7	0.1	0.0	0.0	0.1	1.3	2.5	0.7	1.2	12.3	7.1	0.1	15.9	0.8	6.6	0.0	1.8	3.3	2.8	470.6	206.4	0.3	1.3	0.0	6.5	87.2
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484683	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.9;intestine: 17.5;vagina: 32.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 239.7;Basal respiratory cells: 137.3;Club cells: 146.1;Collecting duct cells: 69.9;Prostatic glandular cells: 62.5;Proximal enterocytes: 91.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.8;EFO-21: 35.9;HeLa: 13.0;SCLC-21H: 16.8;SK-BR-3: 41.2;U-2 OS: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.2	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	12.6	0.8	1.2	3.9	3.2	4.7	20.9	1.6	0.2	1.1	0.1	0.0	7.3	1.2	3.8	0.0	0.1	0.1	0.0	0.1	2.4	0.0	2.1	0.0	0.1	7.6	0.9	0.2	8.1	0.5	0.2	12.5	17.5	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.0	0.3	2.4	32.9	0.1	0.2	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	13.8	0.0	35.9	0.0	0.0	1.7	0.0	0.1	0.0	4.2	0.0	0.0	13.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.8	0.4	0.0	0.0	1.3	8.4	9.4	0.9	16.8	0.0	0.3	41.2	0.0	0.9	0.8	0.0	0.0	0.0	15.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	6.4	1.5	0.0	0.0	30.3	239.7	137.3	8.6	0.1	2.5	1.3	0.7	2.8	146.1	69.9	0.0	0.2	0.1	23.3	0.0	8.8	0.0	36.9	0.5	0.6	1.8	0.0	0.0	1.0	0.0	1.8	3.1	6.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	4.2	38.7	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.9	2.7	0.0	0.1	62.5	91.7	1.6	20.9	0.0	0.0	0.4	3.5	0.0	0.2	2.4	29.1	0.0	0.7	0.8	8.2	45.2
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"esophagus: 69.5;lymphoid tissue: 26.9;skin 1: 76.3;vagina: 36.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.4	0.3	0.7	0.2	0.7	0.2	1.5	0.6	0.8	7.6	0.6	0.2	0.2	0.5	0.3	69.5	1.7	1.3	0.5	0.7	0.9	1.8	0.3	1.8	0.1	0.8	0.7	0.6	0.7	0.2	3.1	1.8	0.4	0.7	1.5	0.2	0.2	7.7	0.9	0.4	76.3	0.3	0.4	0.7	2.6	0.8	2.1	0.7	1.7	0.4	0.1	26.9	8.7	36.9	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.7	0.7	0.6	0.8	0.7	0.9	0.8	0.7	0.6	0.7	0.7	0.7	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
FABP12		ENSG00000197416	"Fatty acid binding protein 12"	A6NFH5	8	81524981-81531378	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 72.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 83.1;Late spermatids: 150.3"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044041	Enhanced					NA	NA					"HPA044041: AB_10962213"		"unprognostic (1.18e-1)"			"unprognostic (7.31e-3)"	"unprognostic (3.07e-1)"									"unprognostic (2.63e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	72.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	83.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	150.3	0.6	0.0	0.0	0.0	0.0	4.1	0.0	2.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.5	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292425	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"esophagus: 33.6;skin 1: 42.2;vagina: 15.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 27.9;Basal squamous epithelial cells: 17.6;Early spermatids: 11.8;Squamous epithelial cells: 26.1;Suprabasal keratinocytes: 64.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 9.9;head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain					NA	NA					"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.2	0.0	0.1	42.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.1	0.6	15.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	27.9	1.1	0.0	17.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	6.5	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.3	1.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	26.1	64.2	0.0	0.0	0.0	0.1	1.9
FOXN1	"FKHL20, RONU, WHN"	ENSG00000109101	"Forkhead box N1"	O15353	17	28506243-28538900	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 18.6;lymphoid tissue: 10.8;skin 1: 40.5;vagina: 11.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Prostatic glandular cells: 5.9;Squamous epithelial cells: 15.9;Suprabasal keratinocytes: 12.4;Urothelial cells: 15.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 7.0;head and neck cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HaCaT: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (1.60e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.68e-3)"	"unprognostic (5.98e-6)"		"prognostic favorable (5.00e-4)"		"unprognostic (2.85e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.5	0.1	0.1	40.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.1	0.0	5.6	0.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.9	1.8	1.2	0.0	0.4	0.6	0.4	0.0	0.3	0.0	0.0	0.8	0.0	2.2	0.0	0.0	0.8	0.3	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	15.9	12.4	1.1	0.1	0.0	0.4	15.4
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 13.0;testis: 5.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Low region specificity"	"Detected in single"			HPA055783	Approved					NA	NA					"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	1.0	0.0	0.0	5.2	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.2	0.7	0.9	0.0	0.2	0.3	1.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 101.8;skin 1: 92.4;vagina: 35.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 48.6;Basal prostatic cells: 38.0;Basal respiratory cells: 49.6;Squamous epithelial cells: 63.8;Suprabasal keratinocytes: 83.5;Urothelial cells: 66.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 36.7;head and neck cancer: 57.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;HaCaT: 90.8;HBEC3-KT: 40.7;hTCEpi: 147.4;RT4: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain					NA	NA					"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.2	0.1	1.1	0.0	0.9	0.0	4.0	0.7	1.3	6.4	0.1	0.1	0.0	0.1	3.4	101.8	0.6	3.4	0.1	1.5	0.4	0.1	0.4	0.3	0.0	0.5	0.4	0.8	0.1	1.1	0.0	0.9	0.7	0.6	5.2	0.1	0.0	14.0	3.2	0.3	92.4	0.2	0.0	0.6	0.1	0.1	2.4	0.5	1.5	0.9	0.1	12.7	7.2	35.2	1.0	29.1	0.3	0.1	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.3	90.8	0.0	40.7	0.0	0.1	0.0	7.0	0.9	0.0	0.0	0.0	0.0	0.1	147.4	0.0	23.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	50.9	0.1	0.0	3.6	1.5	0.0	0.4	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.7	1.3	1.5	0.4	0.5	0.4	0.8	0.6	0.6	0.5	1.0	0.0	0.0	1.1	0.3	0.0	48.6	38.0	49.6	12.5	0.0	2.8	1.9	0.5	0.0	17.2	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	4.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	19.5	0.0	0.0	12.4	0.0	0.0	0.0	1.4	0.0	0.0	63.8	83.5	0.4	0.2	0.0	0.3	66.2
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786624	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 33.4;lymphoid tissue: 12.9;skin 1: 24.8;vagina: 11.5"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 46.5;Basal squamous epithelial cells: 37.5;Squamous epithelial cells: 29.5;Suprabasal keratinocytes: 53.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.8;head and neck cancer: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 3.7;hTCEpi: 1.8;HUVEC TERT2: 2.0;TIME: 5.8"					"Low region specificity"	"Detected in many"			"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	33.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	5.5	0.0	0.0	24.8	0.0	0.0	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	4.0	2.4	11.5	0.1	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.0	1.0	0.0	46.5	0.9	7.4	37.5	0.0	1.5	0.9	3.6	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.1	0.0	3.9	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.1	29.5	53.1	0.0	0.1	0.0	0.0	2.8
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.9;skin 1: 15.4;vagina: 19.0"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 48.9;Late spermatids: 45.3;Paneth cells: 33.0;Squamous epithelial cells: 58.5;Syncytiotrophoblasts: 99.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 17.0;head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 19.7;HaCaT: 37.6;HBEC3-KT: 32.3;hTCEpi: 18.3;PC-3: 13.4;TIME: 55.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039462	Uncertain					NA	NA					"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.1	0.0	0.3	0.8	0.3	0.4	0.9	0.3	0.4	6.1	0.2	6.1	0.3	0.3	0.6	33.9	2.6	0.1	0.1	0.3	0.5	0.8	0.1	1.1	0.1	0.3	0.2	0.3	0.1	0.0	0.3	0.2	6.8	0.4	1.6	4.6	1.2	3.8	0.1	0.1	15.4	1.3	0.3	0.1	0.1	0.1	2.9	0.3	0.3	0.0	0.1	1.7	0.4	19.0	0.7	1.8	0.6	0.0	0.2	0.3	0.1	19.7	0.0	0.0	0.1	0.0	0.5	0.3	0.1	3.5	0.2	0.2	37.6	1.0	32.3	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.2	0.1	18.3	0.1	0.7	0.0	9.8	0.0	0.3	0.3	0.1	2.9	0.1	1.6	0.0	2.0	13.4	0.1	0.0	0.2	0.3	0.5	0.2	0.0	1.9	10.3	0.3	1.9	1.4	0.7	55.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.2	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.5	0.3	0.2	0.3	0.4	0.1	0.3	0.7	0.4	9.6	3.9	0.0	0.4	6.5	8.7	10.5	8.0	1.8	2.0	1.5	9.1	0.0	12.7	1.8	4.2	3.6	0.4	17.3	0.0	1.1	19.4	10.3	1.2	1.5	3.0	0.0	0.0	0.0	4.6	1.1	0.0	9.9	1.3	0.2	1.4	0.2	0.9	0.0	0.0	48.9	6.1	0.6	4.8	45.3	0.3	1.2	1.8	0.0	0.1	1.0	1.0	0.0	0.0	0.5	33.0	0.7	0.3	10.9	9.2	6.6	16.8	6.1	0.0	1.4	0.9	5.8	4.8	58.5	19.6	99.3	0.8	0.1	13.1	23.2
HMSD	"ACC-6, ACC6, C18orf53"	ENSG00000221887	"Histocompatibility minor serpin domain containing"	"A8MTL9, P0C7T4"	18	63949301-63981774	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.9"	"Group enriched"	"Detected in some"	4	"monocytes: 28.4;Oligodendrocytes: 11.1;Spermatogonia: 9.6"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.4;GAMG: 8.6;HDLM-2: 18.8;Karpas-707: 7.1"														"Secreted to blood"	NA	NA						"unprognostic (5.83e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.19e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.14e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.55e-1)"	0.7	0.4	2.5	0.9	3.2	0.0	0.3	4.0	6.1	0.1	1.6	0.4	0.1	0.0	0.0	1.0	0.7	0.0	0.6	2.3	3.0	0.0	0.7	1.9	1.6	5.8	3.8	2.2	0.2	0.2	0.0	0.1	0.0	5.3	0.2	0.5	0.1	0.2	0.0	0.1	0.7	1.0	0.0	4.3	1.1	0.3	0.6	3.2	0.9	0.7	0.1	1.2	0.1	0.5	6.9	3.3	0.0	0.0	0.0	3.2	7.4	0.0	0.6	2.1	0.3	3.9	0.0	0.8	0.0	0.0	0.9	8.6	3.4	1.3	0.2	2.5	18.8	0.0	0.0	0.1	0.0	0.8	0.0	0.0	4.1	0.0	2.7	0.1	1.0	0.0	0.0	0.0	7.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	3.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.5	3.2	4.0	6.1	2.3	3.0	5.8	3.8	2.2	5.3	4.3	3.2	6.9	0.1	3.2	0.0	0.3	0.0	1.7	0.2	3.6	0.0	0.1	0.1	0.1	0.3	0.0	0.9	0.0	0.0	0.4	2.9	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.5	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	2.0	0.0	2.7	0.4	0.3	0.5	0.0	0.0	28.4	0.9	0.0	0.5	11.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	1.5	9.6	0.9	0.1	0.1	0.2	0.1	0.6	0.1
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148136-123150672	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 1.2;kidney: 1.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"REH: 38.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.3"	"CAB013268, CAB022752"	Approved					NA	NA					"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.3	0.6	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0
IGHD3-10	"DXP'1, IGHD310"	ENSG00000211923	"Immunoglobulin heavy diversity 3-10"		14	105904497-105904527	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.3;intestine: 3.7;lymphoid tissue: 4.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	7	"naive B-cell: 5.4"	"Lineage enriched"	"Detected in single"	55	"B-cells: 5.4"	"Cell line enriched"	"Detected in single"	12	"NB-4: 1.1"															NA	NA																							0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD4-17	IGHD417	ENSG00000227800	"Immunoglobulin heavy diversity 4-17"		14	105894508-105894523	"Immunoglobulin genes, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 7.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 14.0;skeletal muscle: 59.3;tongue: 26.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.4;Early spermatids: 32.0;Excitatory neurons: 29.9;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 5.1"							NA	NA						"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.3	0.2	1.5	0.3	1.5	0.2	0.2	1.7	1.7	0.1	2.4	1.5	0.8	0.3	0.1	0.7	0.9	0.8	14.0	1.7	0.7	1.2	0.0	0.2	0.1	0.9	0.9	1.2	0.1	4.0	0.0	0.5	0.1	1.1	0.5	1.2	0.7	1.9	0.2	59.3	0.3	0.7	0.7	0.8	0.0	2.0	1.0	0.8	0.0	0.0	26.0	0.0	0.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	1.5	1.7	1.7	1.7	0.7	0.9	0.9	1.2	1.1	0.8	0.8	1.8	0.0	3.2	3.7	43.4	0.0	0.1	0.1	0.0	0.0	1.0	0.4	0.1	12.1	0.0	1.4	1.8	6.2	0.0	0.1	2.3	1.9	0.1	32.0	1.3	0.0	0.2	2.4	1.7	29.9	9.3	0.0	0.7	7.1	0.8	0.0	0.1	0.0	0.0	0.1	1.7	15.7	5.8	0.0	0.0	1.0	3.2	0.0	0.3	0.0	74.0	0.0	1.6	0.0	3.0	2.2	5.9	5.8	0.0	0.1	0.0	1.4	0.0	1.2	0.9	0.0	1.6	1.0	6.2	5.7	0.0	0.3	0.0	0.0	0.1	1.9	0.1
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium inwardly rectifying channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 7.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8;head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513745-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 423.2;esophagus: 1166.0;skin 1: 1330.1;vagina: 426.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 2789.9;Basal squamous epithelial cells: 8290.4;Squamous epithelial cells: 4637.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"HaCaT: 1156.8;hTCEpi: 1001.5"	"Region enhanced"	"Detected in single"		"white matter: 1.9"	"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		No	No		480000000	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favorable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	2.8	0.3	0.1	0.2	0.1	0.7	423.2	0.1	0.1	71.7	0.1	1.1	1.5	0.3	2.3	1166.0	32.7	2.9	0.6	0.2	0.1	0.3	0.6	4.3	0.0	0.2	0.1	0.0	0.4	1.4	0.0	1.2	0.3	0.2	184.3	1.6	0.0	141.1	4.2	0.7	1330.1	2.3	0.1	0.1	0.3	1.6	8.0	0.1	94.6	0.5	0.0	78.3	9.5	426.8	0.1	56.4	7.4	0.0	0.0	0.0	0.0	0.7	5.3	1.3	0.3	0.2	5.9	20.2	0.0	1.8	0.6	14.0	1156.8	0.0	41.8	0.2	0.6	0.0	0.0	7.7	1.9	0.0	0.1	4.7	0.0	1001.5	2.2	6.9	2.7	3.4	0.0	0.3	0.5	0.2	3.5	0.1	0.5	0.0	3.9	6.2	0.0	0.0	104.9	3.3	5.9	2.6	0.1	1.1	15.0	1.2	0.3	20.3	0.0	18.6	0.3	2.8	0.3	2.2	0.1	0.1	0.0	8.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	6.1	12.8	10.3	0.0	2.7	1309.8	2789.9	1190.9	8290.4	0.6	577.7	670.3	0.8	5.7	287.5	1.8	0.0	0.7	16.9	18.3	1.9	8.5	117.6	4.1	0.7	22.9	4.8	0.0	0.1	7.5	7.7	21.7	4.6	8.2	2.5	0.0	0.0	0.0	0.4	0.0	0.1	10.3	189.2	0.0	61.7	44.4	1.5	17.2	320.2	0.0	0.0	0.2	0.0	0.0	0.1	14.1	10.5	0.4	88.7	872.9	8.6	0.1	57.7	0.6	0.0	0.4	32.1	0.6	0.8	4637.9	193.6	1.2	21.6	0.1	7.2	906.0
KRT28	KRT25D	ENSG00000173908	"Keratin 28"	Q7Z3Y7	17	40792196-40799959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"skin 1: 7.6"	"Cell type enhanced"	"Detected in single"		"Spermatogonia: 1.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.6;endometrial cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			HPA066890	Enhanced					NA	NA					"HPA066890: AB_2685742"																		0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"skin 1: 86.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 41.0;Club cells: 20.4;Ductal cells: 67.3;Pancreatic endocrine cells: 27.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	49	"basophil: 170.8"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 170.8"	"Cell line enhanced"	"Detected in many"		"A-431: 3086.0;A549: 2296.0;MCF7: 700.1;PC-3: 1088.7;U-251 MG: 2151.1"									HPA049778	Supported					NA	NA		130000000			"HPA049778: AB_2680877"	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	0.8	0.0	0.3	0.2	0.4	0.3	3.1	0.3	0.6	0.1	0.1	0.2	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.1	1.0	0.4	0.3	0.0	0.0	2.1	0.2	0.2	86.9	0.2	0.0	0.3	0.2	0.1	0.4	0.4	0.2	0.9	0.0	0.0	0.1	0.1	0.4	3086.0	2296.0	0.0	0.0	0.0	0.0	0.3	18.6	3.2	23.9	2.2	6.7	0.7	0.0	3.0	0.3	1.6	43.2	0.0	0.0	4.2	4.6	0.0	0.0	1.3	0.2	1.4	0.0	0.2	0.0	0.0	0.4	1.1	32.9	0.0	0.0	0.0	1.6	0.2	700.1	0.3	6.4	0.2	0.1	1088.7	0.5	0.0	10.4	0.6	0.2	0.7	0.0	1.0	179.1	11.1	0.1	0.5	12.9	0.2	0.4	564.4	0.2	2151.1	0.3	4.4	3.1	0.4	7.2	0.2	170.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.6	0.4	0.5	0.4	0.3	0.3	0.4	0.3	0.4	0.4	0.1	0.0	0.0	0.3	0.0	0.0	3.3	4.4	0.0	0.0	41.0	4.6	0.3	0.0	20.4	0.0	0.0	0.1	12.8	0.1	0.0	67.3	0.9	1.9	0.3	0.4	0.0	0.0	3.9	1.3	2.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	4.1	0.0	0.4	2.5	0.0	0.1	0.0	1.0	0.0	0.0	6.2	0.0	3.3	27.2	0.0	0.0	0.1	2.6	0.0	0.0	2.0	0.0	0.0	1.2	6.8	0.0	0.1	0.0	0.3	2.9	10.5	0.0	0.0	6.0
LGALS7B	GAL7	ENSG00000178934	"Galectin 7B"	P47929	19	38789200-38791754	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 6193.8"	"Group enriched"	"Detected in many"	10	"Basal keratinocytes: 1529.6;Suprabasal keratinocytes: 5136.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 142.7;head and neck cancer: 185.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"HaCaT: 3.9;OE19: 3.9"									"HPA001549, CAB025100"	Supported				"Intracellular and membrane"	NA	NA		4000000			"CAB025100: , HPA001549: AB_1078938"	"unprognostic (4.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.29e-3)"	4.3	1.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	235.2	0.0	1.5	0.0	1.0	0.0	1475.1	0.9	0.0	2.6	0.0	0.0	2.1	3.0	2.7	0.0	0.0	0.0	0.0	1.4	2.7	0.0	2.2	0.0	0.0	5.1	0.0	0.0	168.6	0.1	10.3	6193.8	1.7	0.0	0.0	22.1	3.1	5.0	0.0	0.2	2.3	0.0	1.6	1.1	841.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1529.6	6.3	253.5	102.4	0.0	1.2	13.3	0.4	0.0	64.4	1.8	0.0	0.0	0.0	0.3	0.0	0.0	5.4	3.1	0.2	3.2	1.2	0.0	0.0	0.2	0.1	3.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	41.3	12.3	0.0	0.3	44.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	2.1	0.3	0.3	9.3	0.0	0.0	1.3	4.2	7.5	1.9	329.6	5136.5	0.0	1.6	0.4	0.1	14.0
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 12.6;testis: 36.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.0"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017770, CAB075742, CAB075743, CAB079929"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	5.5	0.2	0.4	0.2	0.5	0.3	4.5	0.8	1.6	2.3	0.0	0.4	0.3	0.5	0.2	12.6	1.2	0.5	1.3	0.6	0.8	1.6	0.2	0.8	0.2	1.4	0.9	0.5	0.7	0.3	0.0	0.4	2.4	1.9	1.1	0.0	2.4	1.7	0.8	5.4	6.0	0.3	0.1	0.9	0.2	1.1	36.3	0.8	0.6	1.0	1.3	0.6	1.0	5.1	1.0	125.2	2.0	0.0	6.3	2.4	7.9	1.5	131.9	15.3	39.9	24.0	0.2	0.5	0.0	10.9	15.0	14.3	10.8	0.0	7.5	33.5	1.2	0.2	0.1	142.4	0.3	1.9	0.0	0.0	11.7	21.1	29.7	38.0	0.1	3.7	0.0	0.0	0.6	76.2	1.0	0.2	0.3	4.2	4.1	2.0	0.3	0.5	0.2	6.7	1.7	3.7	0.5	206.3	2.7	41.3	6.6	0.5	0.2	5.4	1.9	11.8	273.2	0.2	0.2	0.1	0.3	0.6	0.1	13.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.4	0.5	0.8	1.6	0.6	0.8	1.4	0.9	0.5	1.9	0.9	0.8	1.0	25.6	3.2	0.5	0.0	0.4	38.9	54.2	4.3	21.6	0.6	15.1	49.8	0.2	5.7	9.8	25.8	0.0	13.5	0.3	0.0	0.0	0.8	7.7	3.1	8.5	9.2	0.0	0.0	0.0	0.0	186.7	8.0	0.0	9.0	0.0	0.0	3.3	0.1	6.0	0.0	0.0	0.0	6.1	0.3	28.7	14.8	4.1	4.6	12.4	0.0	0.0	0.5	0.0	0.0	0.1	6.7	1.1	3.0	0.0	105.2	0.0	0.2	3.6	0.6	0.0	17.8	13.1	404.4	105.8	32.2	44.9	25.3	0.7	0.1	0.0	131.4
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752532	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"esophagus: 350.6"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 97.0;Club cells: 378.7;Ionocytes: 71.2;Respiratory ciliated cells: 77.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9;ovarian cancer: 46.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	13	"non-classical monocyte: 440.1"	"Lineage enriched"	"Detected in many"	22	"monocytes: 440.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HaCaT: 2.8;OE19: 1.9"	"Low region specificity"	"Detected in many"							HPA028599	Uncertain				"Intracellular and membrane"	NA	NA					"HPA028599: AB_10603777"		"prognostic favorable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favorable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.3	7.2	0.0	0.0	0.0	0.0	0.0	350.6	0.3	0.2	2.5	0.1	0.0	0.0	1.3	1.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.0	0.0	27.2	0.0	0.1	28.1	0.1	0.0	0.0	0.2	23.4	0.0	0.1	2.5	0.0	0.0	26.5	0.0	48.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	33.7	0.4	2.0	0.1	0.2	20.1	0.0	0.2	0.1	0.0	0.0	440.1	1.6	0.1	10.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	97.0	0.0	0.0	0.1	0.0	0.0	0.0	378.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	5.7	0.4	0.4	0.0	0.0	0.0	71.2	1.3	0.0	0.1	0.0	25.3	0.0	0.0	11.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.0	0.0	0.0	22.3	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.2
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465608	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 1075.4;skin 1: 661.9;vagina: 491.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 158.5;head and neck cancer: 235.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 5.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA		7600000	"Endoplasmic reticulum, Vesicles"		"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	1.7	3.6	0.7	1.7	0.7	6.6	32.5	0.6	1.0	125.1	1.3	1.1	0.5	7.7	1.8	1075.4	3.5	1.4	1.1	0.7	0.8	1.8	1.3	1.6	2.6	0.7	0.7	0.6	9.0	1.3	1.8	2.4	12.4	0.7	12.0	0.7	1.0	184.7	1.3	2.8	661.9	1.6	0.8	0.6	2.2	3.3	1.1	0.7	12.4	1.2	0.2	133.0	55.6	491.0	0.7	38.6	0.6	0.2	0.6	0.3	0.0	15.3	1.5	3.9	1.4	1.9	0.5	42.5	0.4	1.7	1.1	5.6	99.5	0.2	4.4	0.7	0.0	0.3	0.7	4.5	0.8	0.4	0.0	0.9	1.7	37.2	0.2	0.3	1.7	0.0	3.1	0.2	0.1	0.1	114.2	0.9	0.0	0.2	24.3	8.3	0.5	0.0	0.2	1.0	108.2	0.1	0.3	0.5	158.9	1.8	4.7	17.7	0.1	0.0	0.0	0.7	0.5	0.7	0.6	3.0	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.0	1.1	0.1	2.9	1.1	2.6	0.0	5.5	4.7	2.1	0.0	0.0	0.3	0.9	1.2	0.7	0.7	0.6	1.0	0.7	0.8	0.7	0.7	0.6	0.7	0.6	0.7	0.7	0.9	0.0	1.1	0.0	1.3	504.7	102.5	161.2	111.0	0.7	66.6	38.0	0.6	2.8	72.6	14.7	0.0	96.5	2.1	0.9	1.9	1.6	0.1	4.5	4.4	7.5	0.0	0.4	0.0	0.2	87.2	18.1	3.6	24.5	5.7	0.5	0.0	0.3	14.0	3.3	0.1	2.2	24.4	0.3	139.8	0.0	0.6	23.2	147.7	0.0	0.7	4.5	0.0	0.0	0.2	4.7	0.2	0.4	0.0	40.4	0.3	0.7	5.7	0.5	0.0	1.5	10.5	0.1	0.9	811.7	2306.1	715.8	9.6	0.5	1.1	642.9
MAJIN	C11orf85	ENSG00000168070	"Membrane anchored junction protein"	Q3KP22	11	64937517-64972108	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.8"	"Group enriched"	"Detected in some"	8	"Distal tubular cells: 3.9;Proximal tubular cells: 9.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.3"	"Group enriched"	"Detected in some"	10	"CAPAN-2: 7.5;SiHa: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.37e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.69e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-2)"	0.0	0.2	0.3	0.2	0.6	0.1	0.2	2.1	0.7	0.1	0.0	0.1	0.0	0.0	2.0	0.1	1.1	2.9	0.0	0.4	0.1	1.4	1.2	0.2	1.5	0.6	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.3	0.2	0.2	0.1	0.6	0.0	1.2	0.4	0.0	0.4	0.6	0.2	22.8	0.2	0.1	0.9	0.0	1.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.1	0.7	0.4	0.1	0.6	0.4	0.0	0.5	0.4	0.2	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699503-41799456	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.6;testis: 39.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.4"	HPA049240	Approved				"Intracellular and membrane"	NA	NA					"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favorable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	1.3	1.0	1.8	6.8	3.0	12.2	3.0	1.6	2.9	1.5	1.3	6.4	2.6	0.7	0.4	1.6	1.8	1.3	0.9	1.6	1.6	2.4	1.4	4.6	6.7	2.2	3.1	1.9	0.8	0.6	0.1	0.9	0.9	1.9	1.5	3.0	1.3	7.1	0.5	0.5	1.3	8.5	0.8	1.6	22.6	4.4	39.8	5.0	2.6	2.3	0.1	8.2	2.7	1.3	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.3	0.6	0.2	0.5	0.5	0.2	0.2	0.2	0.0	0.0	0.0	6.7	0.0	2.0	11.6	1.3	1.8	1.4	8.5	0.1	0.1	0.0	0.0	0.3	0.5	0.8	0.4	26.8	0.1	0.0	0.0	6.5	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	3.7	1.0	0.5	0.0	0.0	0.1	29.9	5.1	1.2	0.4	2.8	0.1	18.5	7.2	15.7	29.9	5.6	29.1	21.7	30.1	25.8	6.5	15.4	21.7	24.0	1.3	16.9	2.3	2.3	57.2	18.1	1.8	3.0	1.6	2.9	1.6	1.6	2.2	3.1	1.9	1.9	1.6	5.0	2.4	0.7	0.0	3.2	0.0	32.8	0.9	0.3	0.3	0.0	0.6	0.3	0.3	0.9	0.0	0.1	0.0	0.0	0.1	19.9	0.0	0.0	0.1	61.3	0.3	1.0	1.4	0.0	0.4	2.1	0.0	0.2	2.0	2.0	0.1	14.0	0.5	3.3	0.5	7.0	0.0	1.1	2.9	0.0	1.2	3.5	50.8	0.6	11.1	17.8	3.7	15.5	0.1	29.9	1.0	1.1	5.3	0.0	1.2	94.7	0.3	0.1	0.4	0.1	1.1	0.0	0.7	1.7	38.1	26.1	0.0	1.0	0.0	28.4	0.1	0.4	0.3
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195811973	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 19.3;intestine: 18.2;prostate: 15.0;vagina: 15.1"	"Cell type enhanced"	"Detected in many"		"Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 3.4"	"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	2.9	0.0	18.2	0.0	0.0	0.0	19.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.8	0.0	7.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	1.2	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	6.4	15.6	0.3	2.1	0.0	18.5	82.1	0.6	0.0	25.7	2.9	2.5	0.0	193.7	0.0	0.0	0.1	0.3	185.1	0.0	1.6	3.5	6.2	0.2	0.7	16.4	0.0	0.9	5.2	4.3	0.6	163.1	5.1	2.5	0.1	0.0	0.0	0.1	0.0	1.0	193.3	40.7	0.0	0.0	0.7	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	37.5	64.3	0.4	0.8	12.4	1.1	0.2	336.1	0.0	0.0	0.5	11.1	2.1	1.9	0.4	0.0	0.1	1.2	2.3	174.5	319.4
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934229-26212532	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"retina: 15.6;testis: 5.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 156.6;Late spermatids: 58.2;Muller glia cells: 74.8;Spermatocytes: 31.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CAPAN-2: 1.2;HEK 293: 1.5;SCLC-21H: 1.4;U-2 OS: 2.4;U-698: 6.3"	"Not detected"	"Not detected"							"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.7	0.0	1.8	0.1	0.1	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.8	0.3	0.0	0.1	0.0	0.5	0.3	0.2	0.0	0.8	0.0	0.5	0.0	0.4	0.1	0.3	15.6	0.0	0.1	0.0	0.7	0.1	0.0	0.2	0.0	0.2	5.2	0.4	0.2	0.2	0.1	0.2	0.0	0.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.8	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.1	0.6	0.1	0.8	0.5	0.3	0.2	0.4	0.2	0.4	0.3	0.2	0.0	0.5	2.0	0.1	1.8	0.3	0.0	0.0	0.9	0.6	0.3	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.9	0.8	156.6	0.6	0.1	0.3	1.8	0.0	2.2	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.4	0.0	0.0	0.0	58.2	1.2	0.1	0.0	1.9	0.0	74.8	0.0	1.0	0.4	0.2	0.0	1.2	0.0	0.3	0.0	1.0	0.0	3.9	0.0	0.0	2.4	31.7	14.2	2.4	1.0	0.0	0.0	0.0	0.4	0.3
NEUROD2	"bHLHa1, NDRF"	ENSG00000171532	"Neuronal differentiation 2"	Q15784	17	39603536-39609777	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	77	"brain: 95.4;choroid plexus: 31.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.1;Cone photoreceptor cells: 4.2;Enteroendocrine cells: 23.8;Excitatory neurons: 14.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.7;glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	139	"SCLC-21H: 29.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 68.0;hippocampal formation: 76.9"							NA	NA						"unprognostic (5.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.51e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.21e-6)"	"unprognostic (4.20e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.57e-3)"	0.0	0.0	46.2	0.0	51.7	0.0	0.0	67.3	95.4	0.0	31.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	66.1	34.5	0.0	0.0	0.0	0.0	48.8	38.4	50.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	32.3	0.0	0.1	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	46.2	51.7	67.3	95.4	66.1	34.5	48.8	38.4	50.0	49.8	32.3	34.3	50.2	0.1	0.0	0.0	1.0	0.2	0.3	1.1	0.0	0.0	10.1	0.2	0.3	1.5	0.0	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	23.8	0.0	14.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.6	0.2	0.0	1.9	0.1	0.6	1.0	0.5	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	1.8	0.0	1.7	0.4	0.6	0.3	0.0	0.0	0.8	0.4	0.0	0.1	1.1
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 45.4;choroid plexus: 12.1;pituitary gland: 17.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 6.1;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042615, HPA058596"	Enhanced					NA	NA					"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.1	7.6	25.5	0.2	18.5	0.0	0.0	13.3	27.0	0.0	12.1	3.8	0.2	0.0	0.1	0.1	1.3	0.0	0.0	15.9	45.4	0.0	0.0	0.0	0.0	26.0	27.8	18.0	0.0	5.0	0.0	17.0	0.0	26.3	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.0	0.1	15.7	0.0	1.0	0.5	34.0	0.2	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	18.5	13.3	27.0	15.9	45.4	26.0	27.8	18.0	26.3	15.7	34.0	19.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Metabolic proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 39.3;skin 1: 74.3;vagina: 21.6"	"Cell type enriched"	"Detected in single"	12	"Squamous epithelial cells: 4.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.9;head and neck cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HaCaT: 3.8;HDLM-2: 1.6;hTCEpi: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"	NA	NA					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	74.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	7.7	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027734-135034813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 717.3;pituitary gland: 166.0;vagina: 200.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 121.0;Basal squamous epithelial cells: 409.2;Squamous epithelial cells: 1069.0;Urothelial cells: 257.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 141.4;HeLa: 108.9;K-562: 112.1;T-47d: 157.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008743	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	1.2	1.9	0.7	7.8	0.6	0.3	0.6	0.8	0.7	40.3	4.0	7.6	12.2	0.8	0.0	717.3	0.5	1.1	0.1	0.9	1.0	0.1	0.3	0.4	0.1	0.8	0.8	0.6	0.6	0.4	0.0	166.0	2.8	0.8	20.2	2.0	0.1	138.6	0.0	14.2	1.9	7.9	0.4	0.6	0.2	42.2	2.2	0.6	0.0	0.2	20.2	12.7	85.7	200.7	0.8	57.5	36.9	0.0	44.7	1.4	0.9	13.4	9.6	14.6	5.1	2.3	141.4	32.5	59.9	17.6	0.9	12.6	17.6	6.4	25.5	0.3	0.7	48.2	13.4	108.9	38.4	15.6	5.8	0.1	1.4	18.4	0.0	4.9	0.3	0.1	10.1	112.1	0.2	1.9	18.4	0.6	12.3	0.1	4.8	31.8	18.5	1.1	1.2	0.6	17.9	20.2	0.1	48.4	24.1	0.0	0.5	157.5	4.2	1.5	6.1	13.4	3.5	17.0	0.1	0.2	40.7	8.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.8	0.7	0.9	1.0	0.8	0.8	0.6	0.8	0.6	0.6	0.8	0.1	0.0	0.0	0.0	0.2	1.3	121.0	12.8	409.2	1.0	2.5	2.7	2.3	1.5	8.6	0.0	0.0	0.8	0.0	4.2	0.0	0.2	4.2	0.3	0.6	1.2	0.0	50.8	0.0	0.4	2.1	28.8	0.5	0.2	0.0	2.7	0.0	0.0	0.9	0.0	0.0	2.4	6.1	0.0	0.3	5.7	0.3	1.0	0.0	0.0	0.0	0.4	1.0	0.0	0.1	16.9	3.4	0.0	3.1	101.6	0.3	0.2	6.1	1.8	0.0	2.1	4.5	2.2	5.6	1069.0	6.8	7.7	0.9	0.7	2.5	257.3
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496589	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 4054.6;vagina: 1743.1"	"Cell type enriched"	"Detected in many"	21	"Squamous epithelial cells: 1544.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.8;hTCEpi: 2.0;RT4: 1.2"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 8.4"	"Low region specificity"	"Detected in some"			"HPA041874, HPA043317"	Enhanced					NA	NA					"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	1.3	2.1	4.8	0.0	5.0	0.0	0.8	4.6	6.9	393.6	3.5	0.5	0.0	0.6	0.0	4054.6	0.7	0.7	1.2	4.9	5.0	115.0	3.5	0.3	0.0	4.9	4.6	4.6	0.8	3.2	0.0	4.3	0.1	4.6	3.4	0.0	2.6	598.3	0.8	1.0	14.7	0.9	0.3	4.8	0.6	3.5	1.3	4.5	0.8	0.5	0.0	465.6	3.8	1743.1	4.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.0	4.6	6.9	4.9	5.0	4.9	4.6	4.6	4.6	4.8	4.5	4.6	0.0	0.0	0.0	2.0	0.3	1.3	28.9	22.9	6.2	1.0	0.9	0.5	0.7	0.0	47.6	14.7	0.0	0.0	0.0	0.6	15.6	1.5	2.0	0.0	0.1	0.7	0.0	0.0	6.0	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.7	1.4	0.0	1.5	0.0	0.0	0.0	64.4	0.0	4.0	0.3	0.7	4.8	0.0	0.0	34.8	0.0	0.0	1.6	2.8	0.0	0.0	5.4	1.5	0.1	1544.7	17.8	0.0	0.3	0.0	0.2	70.5
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874234	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 213.5;skin 1: 126.8;vagina: 93.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 328.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053343	Enhanced					NA	NA					"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.4	0.1	1.1	0.2	1.2	0.2	16.1	1.3	1.8	13.1	0.8	2.3	0.6	0.8	9.6	213.5	2.7	0.6	0.1	1.2	1.4	3.3	0.2	2.4	0.2	2.2	1.4	1.4	0.3	16.5	2.2	3.0	3.2	2.7	16.8	2.7	0.0	44.6	2.4	0.2	126.8	0.6	0.1	1.0	0.1	1.2	0.3	1.7	2.7	0.5	0.0	23.5	20.9	93.0	2.2	1.6	9.7	0.1	2.7	0.2	0.0	5.2	0.1	0.8	0.4	0.2	4.0	4.4	0.0	2.4	0.0	0.3	77.9	4.5	0.6	0.2	10.5	12.5	0.5	11.3	0.6	0.0	0.5	0.0	0.3	6.0	0.3	0.1	0.4	0.1	2.3	2.1	0.5	0.0	27.2	0.6	2.3	1.7	19.3	3.7	4.0	0.4	1.8	5.1	34.3	4.0	0.8	8.0	328.9	0.2	0.5	40.9	0.3	0.1	0.0	1.1	0.2	0.3	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.3	1.8	1.2	1.4	2.2	1.4	1.4	2.7	1.0	1.7	2.2	0.6	0.0	3.2	0.3	0.5	84.1	42.5	80.9	19.9	0.0	75.2	48.5	0.9	2.8	103.0	29.5	0.0	60.7	1.9	43.1	13.7	107.5	0.0	18.5	1.9	2.5	22.7	0.0	1.5	56.2	6.0	2.0	7.1	25.5	1.3	0.4	0.0	0.0	4.6	0.0	0.5	54.7	67.1	0.0	13.3	0.0	0.0	0.8	32.0	0.0	3.6	0.0	0.0	0.0	0.3	13.8	142.3	0.7	0.1	89.8	1.0	0.9	26.2	0.0	0.0	0.2	7.3	0.0	0.9	375.0	283.0	42.4	1.9	0.0	66.3	275.1
RIBC2	"C22orf11, DKFZp566F0546, FLJ25720"	ENSG00000128408	"RIB43A domain with coiled-coils 2"	Q9H4K1	22	45413693-45432509	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 11.6;fallopian tube: 9.8;testis: 30.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 218.6;Endometrial ciliated cells: 77.5;Late spermatids: 40.4;Respiratory ciliated cells: 101.4;Spermatocytes: 159.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 7.6;CAPAN-2: 7.7;MCF7: 9.2;SiHa: 13.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 14.9"	HPA003210	Approved					NA	NA					"HPA003210: AB_1078347"	"unprognostic (2.55e-1)"	"prognostic favorable (7.08e-8)"	"unprognostic (3.58e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.51e-3)"	"unprognostic (7.21e-3)"	"unprognostic (7.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (9.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.13e-1)"	0.0	0.1	5.0	0.6	0.8	1.9	0.2	0.9	0.6	0.9	11.6	0.5	0.3	0.6	0.4	0.7	9.8	0.4	0.0	0.6	1.9	0.1	0.0	0.8	0.4	2.0	2.2	0.0	0.2	0.2	1.3	1.4	0.3	1.5	0.6	0.3	0.2	0.2	0.1	0.0	0.9	0.5	0.2	2.3	0.1	0.5	30.9	0.8	0.6	0.5	0.0	0.4	0.1	0.5	2.2	5.9	4.0	0.6	0.0	0.0	0.0	0.5	7.6	0.6	1.5	2.1	4.2	7.7	0.0	1.8	0.7	0.0	6.8	0.0	0.0	1.1	0.0	0.2	0.0	5.7	0.2	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.8	0.9	0.0	0.0	0.5	9.2	4.0	2.0	0.9	0.1	2.2	4.5	0.0	0.0	2.1	0.8	3.9	0.0	13.0	2.6	0.0	0.4	4.8	2.8	0.4	0.0	0.0	4.6	0.0	2.2	2.3	0.0	0.0	1.2	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.0	0.8	0.9	0.6	0.6	1.9	2.0	2.2	0.0	1.5	2.3	0.8	2.2	0.2	0.0	0.0	0.0	0.1	0.3	0.8	3.6	0.0	0.0	0.6	0.8	0.2	1.5	7.7	0.0	0.0	1.5	0.4	0.8	1.9	0.1	218.6	77.5	1.8	0.3	0.0	4.0	0.9	0.0	0.6	0.9	0.5	2.5	0.0	0.6	0.0	0.0	1.1	0.0	0.3	1.8	12.2	0.0	0.4	40.4	1.2	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.4	0.1	0.0	101.4	3.6	0.0	0.0	1.9	159.4	22.2	1.2	0.1	0.3	0.4	0.1	1.1	0.3
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113564	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Spermatocytes: 52.3;Spermatogonia: 42.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.3;ovarian cancer: 5.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"A-431: 11.8;HeLa: 39.4;JURKAT: 18.0;SiHa: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057527	Uncertain					NA	NA					"HPA057527: AB_2683457"	"unprognostic (2.75e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	1.5	1.2	1.1	0.7	1.4	2.0	1.6	3.9	1.1	1.5	0.9	1.5	0.5	1.0	1.0	1.2	2.1	0.8	0.6	1.1	0.7	2.7	0.2	1.4	1.0	0.9	0.8	0.7	5.0	9.3	1.3	7.4	0.3	1.5	1.8	0.6	1.3	1.7	0.5	0.5	1.9	1.1	0.8	0.7	1.1	1.0	3.1	0.9	0.8	3.2	0.6	0.7	0.9	1.8	1.0	11.8	0.7	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	5.3	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.0	18.0	0.1	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	3.8	0.0	22.6	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.2	0.5	0.2	1.2	0.2	0.4	0.6	1.1	0.3	0.0	0.1	0.0	0.1	0.2	0.3	1.1	1.4	3.9	1.1	1.1	0.7	0.9	0.8	0.7	1.5	0.7	0.9	1.0	1.1	3.2	6.9	1.3	1.3	2.8	5.6	1.5	13.6	3.0	3.9	4.8	0.6	1.5	6.8	0.0	2.1	0.0	1.1	0.5	62.6	3.8	3.9	0.5	2.5	0.8	4.9	0.0	4.7	0.9	0.2	11.7	1.1	1.1	4.5	1.9	0.4	0.0	0.6	0.0	1.7	2.8	0.0	0.8	1.8	7.5	8.4	1.8	0.0	2.8	0.9	5.1	2.1	0.0	4.4	0.8	1.6	0.7	0.8	4.6	0.7	8.9	2.2	6.4	0.0	6.8	1.7	52.3	42.4	4.5	3.1	0.3	1.8	2.1	1.2	4.5
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 3603.4;urinary bladder: 1108.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 11464.4;Basal prostatic cells: 4796.7;Basal respiratory cells: 10600.9;Basal squamous epithelial cells: 4741.9;Club cells: 3331.1;Prostatic glandular cells: 9446.4;Squamous epithelial cells: 9013.7;Suprabasal keratinocytes: 3626.5;Urothelial cells: 5382.7"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 848.8;head and neck cancer: 1229.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.1"	"Group enriched"	"Detected in many"	5	"HBEC3-KT: 21286.9;RT4: 8382.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		27000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	3.2	2.1	2.6	4.1	2.6	1.0	17.5	2.5	3.6	142.0	2.1	2.7	0.8	2.5	16.2	3603.4	5.7	1.8	3.9	2.4	3.7	348.7	1.7	12.1	0.5	4.1	2.9	2.2	1.9	2.1	0.1	5.5	0.8	3.0	48.5	1.6	0.4	380.2	17.1	3.4	353.0	1.7	1.9	3.3	1.5	3.7	2.8	3.1	6.3	12.0	1.4	419.6	1108.4	753.5	3.6	827.0	9.3	1.1	0.9	10.8	4.2	1.2	10.4	11.5	9.0	7.8	2.1	26.8	1.2	418.3	17.8	18.3	2001.4	1.3	21286.9	9.9	5.4	3.7	3.8	56.2	5.0	4.5	0.7	1.9	8.8	2777.8	24.1	3135.5	21.7	13.2	0.0	0.8	1.5	47.7	3.4	0.2	0.2	2.2	22.3	155.4	1.3	497.9	2.1	502.4	8382.8	16.5	0.5	34.9	5.8	9.0	5.9	3.2	5.7	6.0	12.5	692.6	92.4	280.6	1.9	2.4	4.7	26.5	1.8	24.2	10.1	0.4	0.0	2.3	0.0	1.4	0.4	1.6	1.3	0.3	0.0	0.4	0.3	4.3	0.0	0.5	2.2	1.6	0.7	2.6	2.6	2.5	3.6	2.4	3.7	4.1	2.9	2.2	3.0	3.3	3.1	3.6	1.4	9.6	17.3	2.6	1.0	11464.4	4796.7	10600.9	4741.9	0.0	22.2	35.4	2.9	1.5	3331.1	218.8	0.0	0.7	0.8	3.2	1226.7	24.8	4.5	16.3	2.5	108.2	1.8	3.0	0.1	27.6	1.0	130.8	1.5	24.5	17.1	1.2	0.4	0.1	1.8	0.0	0.0	1.6	789.4	0.8	676.4	8.1	0.6	18.0	759.5	0.0	5.3	1.1	0.0	2.0	0.1	668.7	2.5	0.7	25.9	9446.4	0.8	11.8	560.8	0.1	0.0	5.5	207.0	0.6	3.0	9013.7	3626.5	0.3	37.8	8.9	2.0	5382.7
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 35720.4;esophagus: 24762.8;lymphoid tissue: 9029.8;vagina: 11258.1"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	587.7	54.7	41.9	1256.9	48.1	35720.4	70.6	44.3	88.7	2715.0	61.7	51.0	15.6	23.3	5.5	24762.8	238.3	99.9	119.3	41.4	53.2	100.4	178.2	1071.0	29.7	48.3	46.9	41.2	26.0	52.5	9.7	42.1	207.5	47.8	43.5	14.9	5.6	4019.8	5.1	48.9	262.4	48.1	434.4	44.3	3265.5	94.6	16.3	45.0	284.0	49.2	176.3	9029.8	567.1	11258.1	53.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.9	48.1	44.3	88.7	41.4	53.2	48.3	46.9	41.2	47.8	44.3	45.0	53.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 32501.4;esophagus: 30826.8;vagina: 14142.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	626.6	127.1	17.6	1519.1	24.3	32501.4	191.4	19.5	56.9	3782.1	47.1	123.8	24.3	50.4	2.0	30826.8	490.5	148.7	206.8	17.1	36.4	169.1	286.3	1643.5	69.9	26.7	22.1	16.8	52.0	74.6	11.6	65.9	373.2	26.5	92.1	20.4	3.6	5836.0	9.7	92.9	407.2	121.6	485.4	19.5	5424.7	189.2	16.8	24.8	199.6	91.2	151.7	4416.4	963.6	14142.7	30.9	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	17.6	24.3	19.5	56.9	17.1	36.4	26.7	22.1	16.8	26.5	19.5	24.8	30.9	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 38.7;skin 1: 118.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 79.5;Basal respiratory cells: 353.3;Club cells: 120.7;Ductal cells: 157.8;Extravillous trophoblasts: 82.2;Pancreatic endocrine cells: 276.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 8.0;head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 240.4;fHDF/TERT166: 170.8;HaCaT: 412.8;HBEC3-KT: 131.9;HBF TERT88: 223.0;hTERT-HME1: 130.9;U-138 MG: 219.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"cerebral cortex: 12.9;hippocampal formation: 11.4"	HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		160000	"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.4	0.0	0.0	0.5	0.0	0.0	13.2	0.0	0.0	1.4	0.0	0.7	0.0	0.7	0.0	1.9	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.7	0.0	0.5	118.1	0.0	0.1	0.0	0.0	0.8	0.4	0.0	4.6	0.0	0.0	38.7	0.0	4.8	0.0	28.2	0.1	0.0	0.1	0.0	3.7	0.0	240.4	48.2	36.0	26.6	0.0	1.0	0.1	0.1	170.8	62.5	412.8	0.1	131.9	223.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	8.6	22.9	5.5	130.9	1.8	0.0	0.0	0.0	0.8	21.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.8	0.1	0.2	0.0	219.4	8.1	4.7	22.8	0.1	0.0	0.0	22.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	79.5	0.9	353.3	0.0	0.0	0.1	0.0	0.0	0.0	120.7	0.0	0.0	1.9	0.0	0.5	0.0	157.8	0.1	0.0	0.0	0.5	0.0	0.0	0.2	8.8	82.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	2.0	0.0	3.0	0.0	0.0	0.2	3.6	0.0	1.6	0.0	0.0	0.5	0.3	276.5	1.1	0.0	0.0	4.5	0.0	0.3	13.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	21.9	6.2	0.1	0.0	0.0	8.2
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2481.3;skin 1: 1140.9;vagina: 697.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	2.3	0.8	2.0	11.7	1.7	2.0	29.4	1.7	7.9	169.6	0.5	89.5	49.2	8.1	0.7	2481.3	2.2	21.6	1.2	2.0	2.8	15.8	3.7	56.6	0.2	9.0	1.8	1.3	0.9	2.2	0.1	2.7	1.6	6.0	77.9	32.8	0.6	335.5	3.2	5.0	1140.9	41.1	3.3	2.1	0.9	67.1	0.7	4.3	22.3	2.0	0.1	149.1	169.3	697.7	3.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	1.7	1.7	7.9	2.0	2.8	9.0	1.8	1.3	6.0	2.1	4.3	3.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SHCBP1L	C1orf14	ENSG00000157060	"SHC binding and spindle associated 1 like"	Q9BZQ2	1	182899865-182953525	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1157	"testis: 115.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 593.7;Spermatocytes: 593.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036124, HPA036125, HPA064821"	Enhanced					NA	NA					"HPA036124: AB_2674953, HPA036125: AB_10671834, HPA064821: AB_2685360"		"unprognostic (1.29e-3)"								"unprognostic (1.03e-1)"				"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.44e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	593.7	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	86.9	6.8	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.1	593.1	16.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SHOC1	"C9orf84, FLJ32779, MZIP2, Zip2"	ENSG00000165181	"Shortage in chiasmata 1"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 17.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Endothelial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032108			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.0	2.4	0.9	0.0	0.7	0.1	0.0	2.0	1.4	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.8	2.2	0.0	0.1	0.0	1.2	1.5	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.1	1.1	17.2	1.5	0.0	0.0	0.0	0.3	0.1	0.2	2.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.0	1.1	0.4	0.0	0.0	0.3	0.1	0.0	21.7	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.7	2.0	1.4	1.2	1.8	1.2	1.5	0.5	1.2	0.8	1.5	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOX30		ENSG00000039600	"SRY-box transcription factor 30"	O94993	5	157625679-157671480	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	85	"testis: 81.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 351.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.9;CACO-2: 1.3;HDLM-2: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006159, CAB009382"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB009382: AB_2195963, HPA006159: AB_1080062"	"unprognostic (3.51e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.70e-4)"	"unprognostic (2.53e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.64e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.45e-1)"	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.7	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	81.3	0.2	0.7	0.0	0.0	0.1	0.1	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	351.1	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	71.4	1.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	42.8	11.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132644898-132646051	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055614	Approved					NA	NA					"HPA055614: AB_2682862"											"unprognostic (2.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"				0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SiHa: 47.9"					"Low region specificity"	"Detected in many"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.1	1.3	0.1	0.9	0.3	0.1	0.1	1.5	1.6	1.5	0.3	0.1	0.5	2.5	0.1	0.1	0.0	0.1	1.6	0.4	0.5	1.1	0.0	0.0	0.2	0.4	1.0	0.1	0.1	4.0	0.4	0.3	0.3	0.7	0.1	0.1	0.1	1.7	0.1	0.9	0.1	0.1	0.0	0.0	0.1	31.8	0.5	0.1	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.2	0.9	0.0	0.2	0.3	0.2	2.2	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	47.9	0.3	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.1	1.5	1.6	0.4	0.2	0.4	1.0	0.3	0.0	0.5	0.7	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	26.1	1.2	5.5	0.2	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.0	0.5	0.4	2.1	0.1	0.0	2.4	0.1	0.0	0.3	0.2	15.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	39.4	25.2	0.0	0.1	1.6	0.1	0.6	0.1	0.1
TCP11	"D6S230E, FPPR, KIAA0229"	ENSG00000124678	"T-complex 11"	Q8WWU5	6	35118071-35148610	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	338	"testis: 343.5"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1921.3;Late spermatids: 6899.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.6;WM-115: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048311	Supported					NA	NA					"HPA048311: AB_2680351"	"unprognostic (1.35e-1)"	"prognostic favorable (5.02e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.43e-4)"	"unprognostic (8.09e-7)"	"unprognostic (4.06e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.98e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.54e-4)"	"unprognostic (9.41e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-1)"	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.7	0.1	1.0	0.1	0.1	0.0	0.1	0.5	0.2	0.2	0.1	0.0	0.1	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.0	0.2	343.5	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.1	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1921.3	0.3	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	6899.4	30.1	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	29.0	0.0	0.1	0.0	0.1	3.6	0.0	13.1	0.0	0.1	375.1	26.2	0.0	0.1	0.0	0.0	0.2	0.0	0.2
TLX2	"Enx, HOX11L1, NCX"	ENSG00000115297	"T cell leukemia homeobox 2"	O43763	2	74513463-74517148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.0;retina: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 20.9;Rod photoreceptor cells: 18.0;Spermatocytes: 4.3;Spermatogonia: 7.4"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SH-SY5Y: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062254			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062254: AB_2684727"	"unprognostic (7.30e-2)"	"unprognostic (3.03e-4)"	"unprognostic (9.54e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.40e-1)"	"unprognostic (3.92e-7)"	"unprognostic (2.51e-1)"	"unprognostic (6.86e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.18e-1)"	0.0	2.0	1.0	0.2	0.2	0.0	0.0	0.4	0.9	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.9	0.0	3.4	0.0	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	3.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	3.8	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.9	0.1	0.1	0.6	0.3	0.2	0.5	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	4.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"brain: 7.9"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.9	0.3	0.0	0.1	2.1	0.3	0.0	1.1	2.8	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173880-1197936	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 10.7;fallopian tube: 10.8;testis: 42.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 244.1;Late spermatids: 768.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.5;endometrial cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	32	"SCLC-21H: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA					"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.3	0.0	2.5	0.1	0.7	0.0	1.1	0.7	0.5	0.9	10.7	0.1	0.1	0.2	0.4	0.3	10.8	0.3	0.1	0.9	1.4	0.3	0.0	2.9	0.1	1.9	2.1	0.0	0.0	0.3	0.0	2.1	1.5	1.7	0.3	0.1	0.0	0.3	0.1	0.4	0.2	0.2	0.0	2.5	0.1	0.5	42.2	0.9	0.0	0.2	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.5	0.7	0.7	0.5	0.9	1.4	1.9	2.1	0.0	1.7	2.5	0.9	0.6	14.4	0.0	0.5	0.0	0.3	1.8	0.7	3.0	0.0	0.1	1.4	1.0	0.8	1.5	3.4	0.0	2.1	0.0	0.9	0.9	0.0	0.5	244.1	52.2	0.6	2.1	0.0	0.0	0.2	1.3	1.0	0.3	3.6	6.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.1	0.0	0.0	1.1	768.4	5.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.5	1.0	4.5	0.0	1.5	0.4	0.1	72.5	0.1	6.6	0.9	1.0	9.3	2.1	1.0	2.0	0.1	0.9	0.0	3.6	1.3
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869038	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.1;pituitary gland: 26.4;retina: 11.0;testis: 13.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.7;Cone photoreceptor cells: 27.1;Early spermatids: 25.3;Excitatory neurons: 39.3;Horizontal cells: 32.0;Inhibitory neurons: 42.7;Rod photoreceptor cells: 38.5;Spermatocytes: 29.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 16.3;NTERA-2: 31.7;SiHa: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043275: , HPA055678: AB_2682883"	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	0.1	2.5	7.9	0.4	10.1	0.2	0.1	0.3	17.1	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.1	0.2	8.5	7.6	0.2	0.1	0.3	0.2	4.3	2.7	9.9	0.1	0.4	2.5	26.4	0.0	5.6	0.4	0.1	11.0	0.1	0.1	0.1	0.2	0.3	0.0	0.5	0.3	0.3	13.5	5.1	0.0	0.3	0.0	0.2	0.1	0.2	5.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.5	6.9	0.0	0.4	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	1.1	0.0	1.2	0.0	0.7	0.5	0.0	0.2	1.0	0.8	0.2	0.4	0.0	0.0	0.2	0.3	7.9	10.1	0.3	17.1	8.5	7.6	4.3	2.7	9.9	5.6	0.5	5.1	5.6	0.2	0.0	1.1	2.9	0.2	1.0	0.5	0.1	0.0	33.7	0.2	1.0	1.6	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.5	25.3	0.7	0.2	0.5	0.0	0.0	39.3	0.2	0.1	0.2	1.1	0.2	1.3	0.3	0.0	0.1	0.1	32.0	42.7	0.2	0.0	0.0	0.4	11.0	0.9	0.2	1.8	1.9	0.1	4.4	1.0	16.1	4.5	0.2	0.0	0.0	0.3	0.4	0.0	0.3	1.5	38.5	0.0	0.6	0.2	29.4	15.9	0.0	0.1	0.0	1.5	0.1	0.0	0.4
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 22.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 25.5;Late spermatids: 12.2;Proximal tubular cells: 19.1;Spermatocytes: 37.3;Spermatogonia: 11.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 1.5;SiHa: 5.0;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA058541: AB_2683748, HPA076453: AB_2732310"	"unprognostic (4.49e-2)"	"prognostic favorable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.0	3.1	0.3	0.1	0.3	0.1	0.6	0.2	0.8	0.1	0.0	0.5	0.1	0.3	0.0	0.0	0.2	0.2	0.6	0.4	0.1	0.7	0.1	0.1	0.2	0.3	0.1	0.3	2.4	0.1	0.1	0.6	0.3	0.3	0.1	0.1	0.5	0.1	0.1	0.5	0.3	0.3	0.2	0.0	0.5	0.1	22.0	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.5	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.8	0.4	0.1	0.3	0.1	0.3	0.3	0.0	0.1	0.3	4.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.5	0.3	1.8	0.0	0.0	1.8	2.1	0.0	0.3	0.0	0.0	0.0	25.5	0.0	0.1	1.6	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.3	0.0	2.0	6.1	0.4	0.0	0.0	1.5	0.1	0.0	0.0	0.0	12.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.5	19.1	0.0	0.8	0.0	0.0	0.1	37.3	11.7	0.0	0.1	0.0	0.4	0.5	0.0	0.0
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829434-82840022	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 96.9;skin 1: 139.3;vagina: 52.2"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 33.3;Squamous epithelial cells: 156.8;Suprabasal keratinocytes: 41.1;Syncytiotrophoblasts: 68.1;Urothelial cells: 51.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 20.5;head and neck cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.3;hTCEpi: 7.2;MCF7: 5.4;SK-BR-3: 14.0"	"Not detected"	"Not detected"							"HPA021573, HPA023012"	Enhanced					NA	NA					"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.5	0.1	1.2	0.0	1.1	0.1	5.2	0.5	1.0	12.2	0.0	0.1	0.1	0.2	4.1	96.9	0.6	0.2	0.4	0.7	0.6	0.4	0.1	2.0	0.0	1.2	0.4	0.4	0.1	0.2	2.2	2.9	3.9	1.2	3.3	0.0	0.0	33.9	2.7	12.1	139.3	0.1	0.0	0.4	0.1	0.2	0.4	1.1	5.1	3.6	0.0	14.8	5.0	52.2	2.4	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	1.2	1.0	0.0	14.0	0.0	1.7	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	1.0	0.7	0.6	1.2	0.4	0.4	1.2	0.4	1.1	2.4	0.6	0.0	8.2	0.0	0.0	5.2	14.3	19.6	9.1	0.0	7.4	5.0	0.4	0.0	21.2	0.0	0.0	23.1	0.0	0.0	0.0	0.0	2.4	27.1	3.3	0.9	0.0	0.0	0.4	0.0	1.9	0.3	0.0	33.3	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	10.2	0.0	0.3	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	7.6	0.0	0.1	14.2	0.0	0.0	0.1	1.5	0.0	0.2	156.8	41.1	68.1	0.2	0.0	0.0	51.3
